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RESUMEN 
Acinetobacter baumannii fue considerado siempre como un patógeno de relativa baja virulencia, 
pero durante las dos últimas décadas, este microorganismo oportunista  ha emergido como uno de los 
mayores problemas encarados por el sistema clínico en hospitales de todo el mundo. Como consecuencia 
inevitable de la presión selectiva impuesta por el uso abusivo de antibióticos en el tratamiento de 
infecciones, se han descrito cepas clínicas multirresistentes de A. baumannii,  con una alta capacidad para 
desarrollar diferentes mecanismos de resistencia.  
Atendiendo a los antibióticos β-lactámicos, el principal mecanismo de resistencia es la producción 
de β-lactamasas, que son enzimas bacterianas capaces de degradar el antibiótico antes de que alcance su 
diana en la bacteria, permitiéndole a ésta una gran facilidad de adaptación al medio hospitalario y de 
crecimiento en asociación con su hospedador humano. Estas enzimas pueden ser clasificadas en 
diferentes grupos en base a su secuencia de amino ácidos o acorde a su perfil hidrolítico de sustratos e 
inhibidores. Dentro de esa clasificación, en este trabajo nos hemos centrado en la clase B de las β-
lactamasas, que son un grupo de proteínas con una conservada estructura tridimensional, pertenecientes 
a una conocida superfamilia de proteínas, las metallo-β-lactamasas. 
Esta superfamilia de las metallo-β-lactamasas fue por primera vez descrita por Neuwald en 1997. 
Sus miembros presentan una ubicua distribución a través de los tres dominios biológicos, lo cual sugiere 
una gran importancia funcional así como un origen ancestral.  Son proteínas que se caracterizan por 
compartir un estable plegamiento tridimensional compuesto por cuatro regiones bien definidas, que son 
dos grupos centrales de láminas-beta rodeados a ambos lados por αlfa-hélices que quedan expuestas al 
solvente. En todas las estructuras conocidas hasta el momento, el sitio activo se sitúa entre los dos grupos 
de láminas beta enfrentadas, dónde uno o dos átomos metálicos, preferencialmente zinc, queda unido 
por una fuerte interacción con los residuos altamente conservados que confeccionan el motivo 
característico de esta superfamilia en su sitio activo. Este canónico plegamiento representa el mínimo 
dominio necesario para definir a una proteína funcional dentro de esta superfamilia, aunque gracias a 
diversos dominios adicionales el rango de reacciones químicas que estas proteínas pueden catalizar ha 
sido ampliamente extendido. Los diversos miembros fueron clasificados en 16 grupos, describiendo su 
variedad estructural adicional al plegamiento canónico y sus distintas funciones biológicas. Recientemente 
dentro de esta clasificación, un nuevo grupo 0 fue definido, el cual incluye dos enzimas sin actividad 
conocida por el momento, pero con un característico dominio adicional al canónico de metalo-β-
lactamasa.  
Con el presente estudio, quisimos identificar nuevos posibles miembros de esta superfamilia 
dentro del genoma de A. baumannii, que a su vez pudieran intervenir de algún modo en el mecanismo 
general de resistencia de este conocido patógeno. A través de un meticuloso análisis de su genoma, dos 
genes fueron identificados, ABAYE3862 y ABAYE0164, codificando para dos proteínas putativas 
pertenecientes a la superfamilia de las metalo-β-lactamasas. La predicción de su estructura secundaria 
sugirió el canónico plegamiento en αββα de esta superfamilia, llamando nuestra atención el que ninguna 
de ellas presentase el conservado motivo (HXHXD/H) de unión a zinc en el sitio activo. Estas dos proteínas 
fueron bautizadas como aMBL-1 y aMBL-2, respectivamente, de acinetobacter Metallo-Beta-Lactamase.  
Esos dos genes, ABAYE3862 y ABAYE0164, fueron clonados a partir del ADN genómico de 
A.baumannii y las respectivas proteínas a las que codifican, aMBL-1 y aMBL-2, fueron caracterizadas 
mediante las correspondientes técnicas biofísicas y bioquímicas. Además, su estructura tridimensional fue 
resuelta mediante cristalografía de rayos X, haciendo uso para ello de técnicas de faseo experimental, 
habiendo marcado previamente ambas proteínas con átomos pesados.  
Estas estructuras representan los primeros datos estructurales de dos nuevos miembros de esta 
superfamilia ya que ambas proteínas muestran el típico plegamiento metalo-beta-lactamasa aunque con 
ciertas particularidades. Ambas exhiben un estado de oligomerización mayoritariamente dimérico en 
solución, con un alongado C-terminal. En el caso de aMBL-1 representa un dominio adicional que por su 
similitud con los restantes miembros del grupo 0 de la MBL superfamilia podría darnos algún indicio del 
posible papel de aMBL-1 como transportador de señales extracelulares dentro de la bacteria. En cambio 
para aMBL-2, esa extensión del C-terminal es la que facilita la formación del dímero dejando los dos sitios 
activos de cada monómero enfrentados dentro de la U que forman ambas cadenas.  
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Además, los residuos del presunto sitio activo de aMBL-1 difieren ampliamente del canónico, 
mientras que los de aMBL-2 se asemejan bastante al motivo (HXHXD/H) de unión a zinc e incluso un 
átomo del metal pudo ser definido (aunque con baja ocupación) en su estructura. Con aMBL-2 creemos 
haber contribuido en la comprensión de la evolución de la diversidad molecular que caracteriza a esta 
superfamilia. La proteína aMBL-2 podría definirse como una beta-lactamasa de clase B ancestral que 
Acinetobacter aún conservar en su genoma, con un sitio activo inmaduro y una modesta actividad 
hidrolítica frente a los antibióticos beta-lactámicos. 
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II. INTRODUCTION 
 
1. Acinetobacter baumannii 
Acinetobacter baumannii was considered a low-grade commensal microorganism and a potential 
opportunistic pathogen, but over the last 20 years, it has emerged as a major cause of nosocomial 
infections associated with significant morbidity and mortality in hospitalized patients [1-2]. This fact has 
been attributed to the worldwide expansion of Intensive Care Units that led to a change in the type of 
infections caused by Acinetobacter, and the emergence of multidrug-resistant (MDR) strains to many 
classes of antibiotics [3-7]. 
Genetic determinants of antimicrobial resistance have been described extensively as well as some 
of the mechanisms by which A. baumannii regulates its antibiotic resistance profile. But little is known 
about whether resistance phenotypes are constitutive and therefore static, or whether resistance is 
modulated in response to external signals. In 2010, Hood et al [8], using a proteomic-based approach and 
transcriptional analyses, established that A. baumannii regulates its intrinsic antibiotic resistance profile in 
response to a commonly encountered environmental signal, underscoring the adaptability of this 
organism to growth in the hospital environment and within its host. They found that monovalent cations 
are important environmental signals sensed by A. baumannii. In particular, NaCl in physiological 
concentrations was identified as the responsible for signal sensing thus altering the increased-resistance 
phenotype of A. baumannii [8]. 
The human isolated A. baumannii AYE is a multidrug resistant strain (MDR) responsible for an 
outbreak in France in 2001 [9]. Its genome, made of a single chromosome of 3.9 Mb and 4 plasmids, was 
sequenced with the main goal of identifying the genes concentrated on a resistance island of ca. 86-kb 
long. Whole-genome sequencing approaches comparing MRD A. baumannii isolates with a susceptible 
strain as Acinetobacter baylyi ADP1 have highlighted additional genetic features that potentially 
contribute to antibiotic resistance suggesting that A. baumannii has acquired an extensive regulatory 
capacity as a consequence of growth in association with the human host [10].  
 
2. β-lactam antibiotics and different resistance determinants  
The introduction of β-lactam antibiotics into the health care system represented one of the most 
important contributions to medical science [11].  
β-lactam antibiotics interfere with the final step of peptidoglycan synthesis [12]. The -lactam 
ring is sterically similar to the D-Ala-D-Ala peptide of the cell wall peptidoglycan skeleton. Hence, in the 
presence of the antibiotic, the penicillin binding proteins (PBPs) form a lethal covalent penicilloyl–enzyme 
complex that blocks the normal transpeptidation reaction [13]. The acylated PBP cannot hydrolyze the β-
lactam and subsequent steps in the peptidoglycan synthesis are blocked while the action of autolysins 
destroying the existing cell wall causes bacteriolysis yielding a wall unable to withstand osmotic forces [14-
16]. 
Today, β-lactams remain the most widely used antibiotics but unfortunately, once an antibiotic is 
proven to be effective and enters widespread human therapeutic use, its days are numbered. The use of 
subtherapeutic levels of antibiotics could induce resistance [17], given the large number of bacteria in an 
infection cycle, the rapid generation time and the intrinsic rate of mutation [18]. If one of those mutations 
confers resistance to an applied antibiotic, whereas all sensitive bacteria are killed, the resistant one will 
grow, fill the space vacated by its dead neighbors and become the dominant variant in the population 
[18]. Antibiotics might therefore have a central role in the evolution of resistance other than simply 
providing selective pressure [19].   
The efficacy of β-lactam antibiotics is dependent on accessibility to its targets, the degree of 
resistance to enzymatic inactivation by β-lactamases and the ability of β-lactam to inhibit the target PBPs. 
Altering one or a combination of these parameters may result in bacterial resistance [20].  
 18 
 
A. baumannii has been able to develop primary mechanisms of resistance against most of 
antimicrobial agents [21] that can be summarized as follows: 
a) Alteration of the antibiotic target site. PBPs that exhibit low affinity for β-lactam 
antibiotics and are relatively resistant to inactivation by penicillins. They will be able to 
assume the functions of other PBPs when the latter are inactivated.  
b) Altered permeability of the membrane. Reduced expression of outer membrane proteins 
(OMPs) restricts the entry of certain β-lactams into the periplasmic space of Gram-
negative bacteria and hence, access to PBPs on the inner membrane. Pumping out of 
drugs, through efflux pumps, faster than they diffuse in, resulting in lower intrabacterial 
antibiotic concentrations which is known to be ineffective against the bacteria. 
c) Extracellular secretion of products by vesicles, which enable the extracellular dispersal of 
specific proteins as part of complexes of proteins and lipids. These complexes can act 
synergistically to activate toxic and immune pathways in the host. Vesicles can also help 
bacteria carve out a niche in the environment by modulating interactions between 
neighboring bacteria and between bacteria and the immune system. By this mechanism, 
both pathogenic and nonpathogenic species of A. baumannii interact with prokaryotic 
and eukaryotic cells in their environment. In nonpathogenic bacteria, outer membrane 
vesicles (OMVs) sometimes play a protective role. They could just contribute to bacterial 
survival by reducing levels of toxic compounds or even by using vesicles as an offensive 
tactic to gain a growth advantage over other bacteria. In A. baumannii, OMVs are 
typically spherical, in the 50-200 nm size range, and composed of outer membrane 
proteins, lipopolysaccharides (LPSs), periplasmic proteins, phospholipids, DNA, and RNA 
(Figure 1) [22-23]. 
 
Figure 1: Model of vesicle biogenesis. Outer 
membrane (OM) vesicles are proteoliposomes 
consisting of OM phospholipids and LPS, a subset 
of OM proteins, and periplasmic proteins. 
Proteins and lipids of the inner membrane and 
cytosolic content are excluded from OM vesicles. 
Vesicles are likely to bud at sites where the links 
between the peptidoglycan and OM are 
infrequent, absent, or broken. (LPS) 
Lipopolysaccharide; (Pp) periplasm; (OM) outer 
membrane; (PG) peptidoglycan; (IM) inner 
membrane; (Cyt) cytosol. Taken from Kuehn et 
al, 2005 [23]. 
 
 
 
d) Production of β-lactamases. They are bacterial enzymes that degrade or modify the 
antibiotic before it can reach the appropriate PBP target. The structural similarity that β-
lactamases share with PBPs allows these enzymes to hydrolyze and thereby inactivate 
the β-lactam antibiotic [24].  
 
 
 
3. β-lactamases, antibiotic-modifying enzymes 
β-lactamases probably evolved from PBPs, such as the peptidoglycan modifying DD-peptidases 
[24-25]. Structures and biochemical mechanisms of these proteins are conserved and are widely 
distributed among bacteria. Most likely in this case, evolutionary pressure has selected modifications that 
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allow the degradation of antibiotics. They are globular proteins that confer significant antibiotic resistance 
to their bacterial hosts through the irreversibly hydrolysis of the amide bond of the β-lactam ring resulting 
in biologically inactive products (Figure 2) [26-27]. 
 
Figure 2: Hydrolysis of the essential four-member lactam ring of a β-lactam antibiotic by a β-lactamase. 
 
These enzymes are especially important in Gram-negative bacteria as they constitute the major 
defense mechanism against β-lactam-based drugs [21]. Once expressed, β-lactamases are secreted into 
the periplasmic space where they maintain the local antibiotic concentration below the bactericidal 
threshold.  
Their impact in the treatment of bacterial infections has already been huge, and their potential to 
challenge antimicrobial chemotherapy remains unexhausted [28]. 
β-lactamases were characterized by the Special Commission of the International Union of 
Biochemistry as enzymes acting on amide and cyclic amide bond [28]. Therefore, they have the 
classification number E.C 3.5.2.6 and received the systematic name of β-lactam hydrolases.  
They can be classified based on their amino acid sequences into four classes (classes A-D; Ambler 
classification) or according to functional similarities based on their substrate and inhibitor profiles (Groups 
1 -4; Bush-Jacoby-Medeiros) (Table 1)) [29] [30-33].  
 
Table 1: β-lactamase classification systems 
Ambler                                                               Function; Inhibitors Examples 
Class A 
Penicillinases; Clavulanic acid, 
sulbactam and tazobactam 
TEMs, SHVs, CTX-Ms, SME-1 
Class B 
Metallo--lactamases;  
Zn(II) chelator agents 
IMP-1, VIM-1, Ccr A, NDM-1 
Class C Cephalosporinases; Aztreonam AmpCs, CMY-2, ACT-1 
Class D Oxacillinases; Clavulanic acid OXA-1 
Bush-Jacoby-Medeiros  
Group 1 Cephalosporinases AmpCs, CMY-2, ACT-1, MIR-1 
 
hydrolyze extended-spectrum 
cepalosporins; clavulanate resistant 
 
Group 2 All clavulanic acid susceptible  
2ª Penicillinase PC1  
2b Broad-spectrum penicillinase TEM-1, SHV-1, TEM-2 
2be ESBLs SHV-2, TEM-10, CTX-Ms 
2br Inhibitor resistant TEMs, IRTs TEM-30, TEM-31 
2c Carbenecillin hydrolyzing PSE-1 
2d Oxacillin hydrolyzing OXA-10, OXA-1 
2e 
Cephalosporinases inhibited by 
clavulanate 
FEC-1 
2f Carbapenemases KPC-1, SME-1 
Group 3 Metallo-beta-lactamases IMP-1, VIM-1, Ccr A 
 
hydrolyze imipenem, inhibited by 
EDTA, resistant to clavulanate 
 
Group 4 Miscellaneous 
Penicillinase from Pseudomonas 
cepacia 
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 4. Metallo β-lactamase superfamily 
The metallo-β-lactamase fold represents a stable scaffold that has repeatedly been used during 
evolution to catalyze a diverse range of chemical reactions. Structurally, this diversity is achieved by 
varying the sequence and length of loops near the active site to accommodate different substrates. By 
combining the metallo-β-lactamase core domain with auxiliary substrate- , product- or cofactor-binding 
domains, the range of functions has been extended yet further. 
In 1997, Neuwald et al. defined the metallo-β-lactamase superfamily [34] which includes most of 
the 6000 members distributed over three domains of living organism: Eukarya, Archaea, and Bacteria. This 
ubiquitous distribution suggests its functional importance and the ancient origin of the protein family. 
In order to describe the functional and structural varieties of this superfamily, members were 
classified into 16 groups (Table 1), based on the biological functions [35], without reflecting any 
phylogenetic relationship. A new group has been recently described (number 0) including enzymes from 
Pseudomonas [36] and Archaea [37] of unknown function. 
Table 2: Metallo-β-lactamase superfamily classification 
Group Description 
1 Metallo β-lactamases 
Class B of β-lactamases enzymes with one domain of around 250 amino acids, 
acting on carbon-nitrogen bonds to hydrolyze β-lactam antibiotics. Their 
production is regarded as a resistance mechanism against β-lactams [38]  for 
eubacteria.  
2 Glyoxalases II 
Glyoxalases II present a N-terminal metallo-β-lactamase domain [39]. They 
catalyze the hydrolysis of the thioester of S-D-lactoglutathione to produce 
glutathione and D-lactic acid. 
3 
Flavoproteins and rubredoxin 
oxygen: oxidorreductase  
They contain two distinct domains. One flavodoxin-like domain and a second 
metallo-β-lactamase domain. These enzymes carry out a terminal reaction in 
an unique oxygen scavenging pathway that enables the anaerobe to survive 
under aerobic conditions [40]. 
4 tRNase Z-family 
Enzyme with an exosite which is not required for their phosphodiesterase 
activity but it is essential for pre-tRNA processing and tRNA binding. 
5 Cyclases 
Type II polyketide synthases are bifunctional enzymes, which shows both 
cyclase activity [41] and dehydrase activity [42-43]. 
6 
Cleavage and polyadenylation 
specificity factor 
Proteins involved in the processing of mRNA 3´-ends [44]. This group includes 
the 100-kDa [45] and 73-kDa [46] subunits of the mammalian cleavage and 
polyadenylation specific factor, and a subunit of the yeast polyadenylation 
factor I [47]. 
7 DNA cross-link repair  
Enzymes involved in the repair of DNA interstrand crosslinks which induce 
lethal DNA damage. Upstream of the β-lactamase-like domain, they could 
have a DNA ligase I domain or a zinc finger domain with a very high diverse 
linker region connecting both domains [47-48]. In addition, members of this 
group share a region called β-CASP domain downstream of the metallo-β-
lactamase domain [49]. 
8 
DNA uptake for natural genetic 
transformation 
Proteins involved in DNA uptake for natural genetic transformation [50-51]. 
They may cleave exogenous DNAs into small fragments to facilitate genetic 
transformation. 
9 Choline binding Protein E 
Known as teichoic acid phosphorylcholine esterase from Streptococcus 
pneumoniae [52]. This enzyme is involved in removing phosphorylcholine 
residues from the cell wall, such as teichoic acid and lipoteichoic acid [53]. 
10 phnP protein Enzyme involved in the organophosphonate catabolism in bacteria [54]. 
11 
CMP-N-acetylneuraminate 
monooxygenase 
Key enzyme for N-glycolylneuraminic acid synthesis [55]. 
12 
N-acyl homoserine lactone 
hydrolase 
The quorum-quenching AHL lactonase (AiiA) from B. thuringensis [56]. 
13 Alkyl sulfatase Identified as a determinant of sodium dodecyl sulfate biodegradation [57]. 
14 Carbofuran hydrolase 
Enzyme composed of two repetitive MBL domains, capable of the hydrolysis 
of the insecticide carbofuran [58].  
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15 Methyl parathion hydrolase 
This enzyme from Plesiomonas sp. M6 is able to degrade the insecticide, 
methyl parathion. 
16 
3´,5´-cyclic nucleotide 
phosphodiesterase 
Low-affinity cAMP phosphodiesterase in Saccharomyces cerevisiae that 
controls the level of cAMP in yeast cells [59]. The same enzyme derived from 
Vibrio fisherii is present in the periplasm, and it is involved in the use of 
extracellular cAMP as a source of carbon, nitrogen and phosphorus for 
growth. 
0 Unkown function 
PqsE a “PQS response protein” from Pseudomonas [36] and ST1585 from 
Sulfolobus tokodaii [37].  
 
The general common structure of these enzymes is based on the four-layer αβ/βα fold, composed 
by two central β-sheets with solvent-exposed α-helices (Figure 3). Each half of the molecule comprise a β-
strand and two α-helices and they can be superposed by a 180° rotation around a central axis, suggesting 
that the structure might have arisen from the gene duplication [60]. In all known structures, the active site 
is located at the external edge of the β-sandwich. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Metallo-β-lactamase superfamily overall structures. The metallo-β-lactamase domain is represented in blue (helices), 
green (strands) and grey (loops). Zinc and iron ions are shown as grey and beige spheres, respectively. (a) BcII, class B β-lactamase 
from Bacillus cereus (group 1) (b) Glyoxalase II (group 2) with the additional α-helical domain in violet, (c) ROO (group 3) with the 
additional flavodoxin-like domain in violet, (d) phosphorylcholine esterase (Pce)  (group 9) domain of the virulence factor choline-
binding protein E with the elongated loop lying on the top of the active site represented in yellow, (e) N-acyl homoserine lactone 
hydrolase (group 12) , (f) MPH monomer (group 15), (g) SdsA1 (group 13) monomer with the additional central dimerization 
domain in pink and C-terminal domain in violet, (h) ZiPD (group 4) monomer with the 50 amino acids exosite in salmon, (i) 
TTHA0252 with the β-CASP (group 6 and 7) domain in hotpink. (Taken from Bebrone et al, 2007 [61]). 
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Characteristic motif of the metallo-β-lactamase domain can be detected in the sequence of a 
large number of hypothetical genes in the GenBank [62]. They majority of these proteins have not been 
functionally or structurally characterized yet [61]. 
It should be noted that some members of this superfamily contain additional domains, suggesting 
that a functional diversification has occurred during evolution. The following figure is a schematic diagram 
showing different domains present in members of the superfamily (Figure 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Schematic representation of the domain organization of the metallo-β-lactamase superfamily groups. Distinct domains 
are represented by colored boxes. The upper ruler indicates the number of amino acids Taken from Daiyasu [35]. 
 
A brief description of the groups where only residues from the metallo--lactamase domain are 
involved in its function will be presented. 
 
4.1. GROUP 1: CLASS B β-LACTAMASES (METALLO-β-LACTAMASES, MBLs)  
The MBLs (Ambler class B, Bush-Jacoby-Medeiros Group 3) are a diverse group of enzymes all 
sharing a common αβ/βα fold, in which the catalytic active site is located in an open cleft at the interface 
between the two domains and contain one or two Zn(II) ions (Figure 3a). Each metal site shares elements 
from both halves of the sandwich. The conserved His-X-His-X-Asp/His motif is the most characteristic 
signature of this superfamily and its integrity is maintained by a second shell that orients and polarizes the 
histidine ligands [63]. Zinc ions are 3.5-3.7 Å apart, with a metal-bridging water molecule positioned 
asymmetrically with respect to the binuclear metal center. 
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Many MBLs genes are present in environmental species constituting reservoirs of β-lactam 
resistance genes [44, 47-49]. MBLs are found as metal-free in vivo, binding zinc only in presence of the 
substrate [64]. Moreover, mutations of those amino acids present in the active site not belonging to the 
metal binding conserved motif dramatically reduce the substrate binding properties but retain the β-
lactam-hydrolyzing activity [65-66]. Crowder et al. [63] have shown that the most important determinant 
in the broad substrate specificity of MBLs is the Zn (II) coordination shell that determines the productive 
interactions with the functional groups of the different substrates. Meanwhile, additional protein motifs, 
such as the conserved residues and the flexible loops, may play only minor roles in stabilizing the enzyme-
substrate complex.  
The MBLs classification task was complicated due to the low degree of sequence similarity among 
the different subclasses, but has been facilitated by the availability of X-ray structures, which allowed the 
identification of relevant secondary structure elements. Based on a combination of structural features, 
zinc affinities for the two binding sites and hydrolytic characteristics the MBLs are currently classified into 
three different lineages, identified as subclasses B1, B2, and B3 (Figure 5).  
 
 
Figure 5: Active sites of the three subclasses. B. cereus BcII (subclass B1, left), A. hydrophila CphA (subclass B2, center), and F. 
gormanii Fez-1 (subclass B3, right). Zinc ions are rendered as gray spheres and residues are represented in ball-and-stick mode 
(nitrogen, blue; carbon, light blue; oxygen, red; and sulphur, yellow). 
 
 
4.2. GROUP 2: GLIOXALASE II 
The glyoxalase system consists of two distinct enzymes, glyoxalase I and glyoxalase II, that 
catalyse the conversion of toxic 2-oxoaldehydes into the corresponding 2-hydroxycarboxylic acids using 
glutathione (GSH) as a cofactor. This system has been found in many organisms ranging from bacteria to 
humans [67].  
The substrate for glyoxalase I is the thiohemiacetal produced when GSH reacts non-enzymatically 
with a 2-oxoaldehyde (Figure 7). Glyoxalase I catalyses the isomerisation of thiohemiacetal to produce a 
thiolester of GSH and the corresponding 2-hydroxycarboxylic acid. Glyoxalase II then catalyses the 
hydrolysis of the thiolester generating 2-hydroxycarboxylic acid and free GSH. The primary physiological 
function of the glyoxalase system appears to be detoxication of methylglyoxal, a metabolic byproduct [68]. 
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Figure 6: The glyoxalase system. GSH represents reduced glutathione (g-L-Glu-L-Cys-Gly). Glyoxalase II is a thiolesterase that 
catalyses the hydrolysis of S-D-lactoylglutathione to form glutathione and D-lactic acid. Taken from Cameron [39]. 
 
Glyoxalase II, GLX2, is made up by two domains (Figure 3b). The N-terminal domain shows the 
expected similarity with the MBLs, a four-layered β-sandwich containing a binuclear zinc-binding site. The 
smaller C-terminal domain is unique to this enzyme and consists mainly of α-helices situated at one edge 
of the main core. This typical domain is considered to be essential for substrate binding [39, 69]. 
The canonical GLX2 enzyme shares most of the key zinc binding residues of MBLs but in some 
members of this family structural differences can be observed.  YcbL from Salmonella enterica serovar 
Typhimurium binds a single metal ion and has lost some recognition determinants for the glutathione 
substrate. Despite these changes, it has a robust GLX2 activity. 
Moreover, several GLX2 have been characterized with different ratios of iron, zinc, and 
manganese ions in the active center displaying similar activities all the forms. This metal promiscuity can 
be explained by the presence of a conserved Asp residue acting as a second-shell ligand that increases the 
hardness of the metal binding site, therefore favoring iron uptake in GLX2. 
 
 
 
 
 
Figure 7: Comparison of the YcbL metal binding 
site (PDB code 2xf4) with the diion site in GLX2 
(PDB code 2qed) both from S. typhimurium. 
This overlay indicates that the YcbL zinc site 
corresponds to the D-H-D-H site in GLX2. For 
GLX2, the second iron ion is bound at the H-H-H 
site, which in the case of YcbL is occupied by a 
water molecule. The carbon atoms of GLX2 are 
colored in pink and those of YcbL are in green. 
Iron ions are shown as yellow spheres and zinc 
ion as a grey sphere. Water molecule is 
rendered as a blue sphere. 
 
 
 
 
 
4.3. GROUP 4: tRNASE Z-FAMILY 
The elaC gene product from Escherichia coli (designated ZiPD [70], ecoZ [71], tRNase Z [72], or 
RNase BN [73]) is an enzyme with limited in vivo 3´ tRNA-processing endonuclease activity thats belongs to 
the tRNase Z family. It is not required for cell viability and its physiological role remains unknown. 
Although, the initial functional assignment in the literature was as the arylsulfatase/ElaC family, Vogel et 
al. [70] demonstrated that this was a wrong annotation. This enzyme has phosphodiesterase activity and 
is strongly dependent on the presence of zinc. 
This protein is present as homodimer, with each monomer exhibiting the typical MBL fold (Figure 
3h). Mono- or binuclear metal binding sites are identified in part by residues from the conserved sequence 
motif HXHXD/H [62]. Additional weakly conserved amino acids and water molecules complement the 4–6-
fold Zn (II) coordination. An extra domain extending from the main body of the protein, called exosite, is 
necessary for tRNA recognition but is not required for the intrinsic phosphodiesterase activity or for 
dimerization [74]. It has been suggested that the exosite acts as a clamp to lock pre-tRNA into the correct 
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orientation for catalysis, using one monomer to bind the substrate and the other to catalyze hydrolysis 
with the homodimer capable of cleaving two pretRNA molecules at once [75]. 
 
4.4. GROUP 5: TYPE II POLYKETIDE SYNTHASES 
Polyketides are a large group of secondary metabolites, exhibiting remarkable diversity in their 
structure and function [11].  They are synthesized by sequential reactions catalyzed by polyketide 
synthases (PKSs), large multienzyme protein complexes that contain many different enzyme active sites 
(acyltransferase, keto-syntase, methyltransferase…).  The biosynthesis occurs in a stepwise manner from 
simple 2-, 3-, 4-carbon building blocks such as acetyl-CoA, propionyl CoA, butyryl-CoA and their activated 
derivatives, malonyl-, methylmalonyl- and ethylmalonyl-CoA.  
The iterative Type II systems consist of complexes of mono-functional proteins exemplified by the 
PKS from Streptomyces coelicolor [42]. In these synthases, active sites are distributed among several 
smaller, typically monofunctional polypeptides. Type II synthases catalyze the formation of compounds 
that require aromatization and cyclization, but not extensive reduction or reduction/dehydration cycles. 
These PKSs are analogous to bacterial Fatty Acid Synthases and are involved in the biosynthesis of 
bacterial aromatic natural products such as actinorhodin, tetracenomycin and doxorubicin. 
 
4.5. GROUP 10: PhnP PROTEIN 
Phosphorus (P) is a nutrient of fundamental importance in the cell physiology of bacteria and 
achieve this, E. coli has evolved several gene systems whose products allow for P acquisition and 
assimilation from a variety of compounds [76]. These compounds participate in the high-affinity P 
inorganic transport, for uptake of glycerol-3-phosphate, for hydrolysis of phosphomonoesters, for passage 
of polyanions into the periplasm, and for the degradation of phosphonates (Pn). 
Pn are similar to phosphate esters but have a direct carbon-phosphorus (C-P) bond instead of a 
carbon-oxygenphosphorus (C-O-P) bond. Unlike the C-O-P bond, the C-P bond can be extremely stable. All 
genes for phosphonate (Pn) utilization in E. coli are in a large cluster of 14 genes. 
The phnP gene encodes for a phosphodiesterase that plays an important role within the bacterial 
CP-lyase pathway by recycling a “dead-end” intermediate, 5-phospho-α-D-ribosyl 1,2-cyclic phosphate, 
that is formed during organophosphonate catabolism. PhnP is a dimeric enzyme with a dinuclear active 
site that is typical for the MBL superfamily, as well as a structural zinc ion that is conserved in PhnP 
homologues [77]. Its in vivo substrate is 5-phospho-α-D-ribosyl 1,2-cyclic phosphate, which is a “dead-
end” intermediate generated by the CP bond cleaving step in the CP-lyase pathway [78-79] PhnP 
regiospecifically converts this cyclic intermediate to α-D-ribosyl 1,5-bisphosphate, the putative initiator of 
the CP-lyase reaction. 
 
4.6. GROUP 12: N-ACYL HOMOSERINE LACTONE HYDROLASE 
Over 50 species of Gram-negative bacteria are known to produce N-acyl-L-homoserine lactones 
(AHLs) as signaling molecules used in quorum-sensing pathways that indirectly sense cell density and 
regulate communal behavior [80].  
Quorum-sensing can be disrupted by enzymes that can hydrolyze either the amide [81] or the 
lactone [82] moiety of AHL-signaling molecules.  
Currently, the best characterized quorum-quenching enzymes catalyze the opening of the AHL 
ring by hydrolyzing lactones to the corresponding γ-hydroxy acid. AiiA lactonases reduce AHL 
accumulation, alter swarming motility, and decrease the expression and secretion of numerous virulence 
factors. They are members of the MBL superfamily and contain two zinc ions in their active sites (Figure 
3e). 
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4.7. GROUP 13: ALKYL SULFATASE 
The first member of group III sulfatases is SdsA1 of P. aeruginosa [57], a secreted sodium dodecyl 
sulfate (SDS) hydrolase that allows the bacterium to use primary sulfates such as the detergent SDS as the 
sole carbon or sulfur source. 
Homologues of SdsA1 are found in many pathogenic and some nonpathogenic bacteria. The 
crystal structure of SdsA1 reveals three distinct domains (Figure 3g). The N-terminal catalytic domain with 
a binuclear Zn cluster, the central dimerization domain ensures resistance to high concentrations of SDS, 
while the C-terminal domain provides a hydrophobic groove, presumably to recruit long aliphatic 
substrates [83]. 
 
4.8. GROUP 15: METHYL PARATHION HYDROLASE 
The dimeric enzyme methyl parathion hydrolase isolated from Pseudomonas is a Zn(II)-containing 
enzyme (Figure 3f) that catalyzes the degradation of the organophosphate pesticide methyl parathion to 
produce p-nitrophenol and phosphate. Despite the lack of any sequence or structural homology with 
phosphotriesterase, there are obvious similarities in their metal-binding centers that suggest a common 
catalytic mechanism. An aromatic cluster formed by three amino acid residues oriented at the entrance to 
the catalytic center plays a key role in enzyme affinity to methyl parathion [84].  
 
 
 
 
 
 
 
 
Figure 8: The methyl parathion hydrolase active site. 
The carbon atoms of the active site residues are 
colour in orange. Zinc ions are shown as grey spheres 
and the bridging water molecule is in blue.  Residues 
forming an aromatic cluster at the entrance of the 
catalytic center (Phe119, Trp179, Phe196) are shown 
in yellow. 
 
 
4.9. GROUP 16: 3´,5´-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 
3',5'-Cyclic nucleotide phosphodiesterase (PDEs) converts 3',5'-cyclic nucleotides (e.g., 3',5'-cyclic 
AMP [cAMP] and 3',5'-cyclic GMP [cGMP]) to their corresponding 5'-nucleoside monophosphates. 
The classification of all PDEs in classes I, II, and III shows evolutionary characteristics: All PDEs 
from higher eucaryotes (vertebrates, Drosophila, and Caenorhabditis) and only few from fungi belong to 
PDE class I, whereas PDE class II consists of several enzymes from fungi as lower eucaryotes and one from 
bacteria (the periplasmic PDE from Vibrio fischeri [85]). PDE class III consists, as far as is known, only of 
enzymes from procaryotes. 
In general, PDEs enzymes show the typical secondary structure arrangement for members of the 
MBL superfamily but each class posses a defined motif in their active center. PDE from class I conserve a 
C-terminal catalytic domain of about 250 amino acids, which includes two invariant motifs of the formula 
H(X)3H(X)25–35D/E containing the residues that form the two metal ion binding sites that usually are 
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occupied by Zn2+ and Mg2+/ Mn2+ [86-87]. One structure of the catalytic domain of human PDE4B2B was 
solved [86] providing detailed insight into the mechanism and structure of this active site. 
Members of PDE class II share a conserved motif containing three histidine residues in the 
signature sequence HXHLDH which may be part of a metal ion binding site as it is known that the enzyme 
from Vibrio fischeri is Zn2+ dependent [88]. Further details about this active site are not yet known. 
E. coli cpdA gene represents the first member of PDE class III does not have structural homologs 
in higher organisms. And although the structural and functional organization of its catalytic site is 
comparable to the rest of members of the dimetallophosphoesterases, any scheme for its catalytic site has 
been yet developed.  
 
4.10. GROUP 0: PqsE ENZYME 
P. aeruginosa integrates the biosynthesis of virulence factors and the generation of biofilms 
under the quorum sensing control [89], a signal transduction mechanism involving the production of small 
freely diffusible “autoinducer” molecules that activate their cognate regulatory proteins. The 
“Pseudomonas quinolone signal” (PQS) is produced from genes encoded in the pqs operon, which in 
addition to the biosynthetic enzymes PqsA-D contains a fifth gene, pqsE, that is not required for 
production of PQS but whose disruption leads to loss of signal transduction in several operon-dependent 
processes. PqsE was hence termed “PQS response protein”, but its exact mechanism of action is unknown.  
The overall fold of this protein resembles that of a typical MBL hallmarked by an αβ/βα sandwich 
core structure. In comparison to other members of this superfamily, the monomeric PqsE has two 
additional α-helices at its C-terminus that cover the active center and that might be involved in the control 
of substrate binding. 
PqsE contains a redox-stable Fe(II)/Fe(III) center (Figure 9), in contrast with other proteins with 
the same first metal coordination sphere usually dependent on zinc binding. The number of functionally 
assigned proteins with two-iron centers within the superfamily is relatively small. 
A copurified ligand assigned as benzoate was found in the crystal structure (PDB code 2q0i), its 
location coincides with the substrate binding site in related enzymes, and its carboxylate group 
participates in coordinating one of the two metal ions of the active center. It has been suggested that the 
regulatory effect of PqsE is mediated through a chorismate derived molecule, a central metabolite 
distributed into numerous tightly regulated pathways [90]. 
 
 
 
 
 
 
 
 
Figure 9: The iron binding site in PqsE with the copurified 
benzoate-shaped ligand (BEZ). The carbon atoms of the active 
site residues are colour in green. Iron ions are shown as black 
spheres and the bridging water molecule is in blue. The BEZ 
molecule is in yellow.   
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PqsE exerts its physiological role by acting as a hydrolase but also, by controlling the expression of 
important virulence factors like elastase and pyocyanin in P. aeruginosa and possibly also functions in a 
number of other pathogenic bacteria [91-93]. Furthermore, PqsE was found to slowly hydrolyze 
phosphodiesters including single- and double-stranded DNA as well as mRNA and also thioesters, but this 
activity seems too low to be meaningful. 
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II. OBJECTIVES 
 
Acinetobacter baumannii has emerged as an important oportunistic pathogen and therefore, 
represents one of the most challenging problems facing modern medicine. This microorganism has the 
ability to develop several resistance patterns starting from precursor resistance genes under the 
appropriate selection pressure. Among them are the class B β-lactamases. They are bacterial enzymes that 
show the canonical β-sandwich fold belonging to the metallo-β-lactamase superfamily, a wide group of 
enzymes with an important functional diversity. 
The goal for the present study was to identify targets in A. baumannii associated with multidrug 
resistance. This approach was designed through an acurate analysis of the genome of this pathogen. Two 
genes, ABAYE3862 and ABAYE0164, encoding for two putative proteins belonging to the MBL superfamily 
were selected. Their secondary structure predictions suggested the canonical αββα fold typical for this 
superfamily, besides the presence on a non-canonical zinc binding motif in their amino acid sequences. 
We have called these proteins aMBL-1 and aMBL-2, respectively, from acinetobacter Metallo-Beta-
Lactamase family.  
 
With these premises, the following objectives were proposed for the present project: 
 
 To describe an optimal protocol for the production and the purification of aMBL-1 and aMBL-2, 
for further functional and structural studies. 
 To characterize aMBL-1 and aMBL-2 by biophysical and biochemical techniques, including 
enzymatic activity assays against β-lactam antibiotics and a broad collection of general 
chromogenic substrates. 
 To determine the 3D-structures of aMBL-1 and aMBL-2 by X-ray crystallography and characterize 
the structural differences that could shed light on function.  
 To classify these new members into the MBL superfamily according to their structure-function 
relationship with other related enzymes. 
MATERIALS AND 
METHODS 
 II.MATERIALS AND METHODS 
The development of efficient DNA sequencing methods has led to the achievement of the DNA 
sequence of entire genomes from different strains of Acinetobacter baumannii. In this study, the use of 
bioinformatics tools was essential for protein structure prediction from the target genes. Indeed, it 
provided the right design of different constructions for cloning. In a brief outline, the routine sequence 
analysis performed (used websites are indicated by brackets) is shown in next figure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Cloning 
Genomic DNA was isolated from A. baumannii strain AYE [94] kindly provided by Dr. Germán Bou 
from Hospital A Coruña (Spain). Enzymes, buffers and solutions used for DNA synthesis by polymerase 
chain reaction (PCR), DNA restriction assays, DNA ligation and recombination are shown in Table 3. 
Multiple sequences 
Alignment (Multiple alignment) 
Phylogenetic analysis 
(Phylodendron) 
Alignment (ClustalW, MultAlin) 
Homology detection & structure prediction 
(HHpred) 
 
Protein Data Bank (PDB) 
 
Multiple sequences 
MW, pI, aa composition 
(ProtParam) 
Secondary structure prediction 
(PSIpred) 
Disordered regions (GlobPlot) 
Prediction of protein 
crystallizability (Xtalpred) 
 
Signal sequences (SignalP3.0) 
Single sequence 
Similarity search (BLAST) 
 Features 
Similarity search (BLAST) 
PCR primer design (Amplify1.2, MBCF) 
Translation (ExPASy) 
Restriction sites (Webcutter) 
 
Single sequence 
Routine sequence analysis 
DNA Protein 
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Table 3: Enzymes for DNA-subcloning 
 Manufacturer Reaction Conditions  1X Buffer Composition 
BamHI  NEB 
1X NEBuffer 3 
supplemented with 100 
μg/ml Bovine Serum 
Albumin (BSA) 
50 mM Tris-HCl pH 7.9 @ 25°C, 100 
mM NaCl, 10 mM MgCl2, 1 mM 
Dithiothreitol (DTT) 
EcoRI  NEB 1X NEBuffer EcoRI 
100 mM Tris-HCl pH 7.5 @ 25°C, 
50 mM NaCl, 10 mM MgCl2, 
0.025 % Triton X-100 
XbaI  NEB 
1X NEBuffer 4 
supplemented with 
100 μg/ml BSA 
20 mM Tris-acetate pH 7.9 @ 25°C, 
50 mM potassium acetate, 
10 mM Magnesium Acetate, 
1 mM DTT 
NcoI  NEB 1X NEBuffer 3 
50 mM Tris-HCl pH 7.9 @ 25°C, 100 
mM NaCl, 10 mM MgCl2, 1 mM 
Dithiothreitol (DTT) 
T4 DNA ligase Fermentas T4 DNA Ligase Buffer 
40 mM Tris-HCl pH 7.8 at 25°C, 
10 mM MgCl2, 10 mM DTT, 0.5 mM 
ATP  
DpnI NEB 1X NEBuffer 4 
20 mM Tris-acetate pH 7.9 @ 25°C, 
50 mM potassium acetate, 
10 mM Magnesium Acetate, 
1 mM DTT 
 
1.1. PCR AMPLIFICATION AND SUBCLONING 
DNA for subcloning was amplified by PCR using specific primers individually designed for each 
sequence tag. The PCR primers used for the amplification of the different gene constructs were 
synthesized by Sigma-Aldrich. Primers were designed to a melting temperature Tm of more than 50° C.  
The melting temperature (Tm) for oligonucleotides were calculated by the following formula [95]: 
Tm = 81.5 – 16.6 + 0.41(%G+C) – 600/l 
where:  %G+C : G/C content in % and l : number of basepairs. 
Primers were checked for self-complementary or two primers complementary and mispriming 
with the program AMPLIFY (Bill Engels, University of Wisconsin, Madison, USA) using default parameters. 
Detailed descriptions of the oligonucleotides used for the cloning of the two gene lactamase constructs 
are summarized in Table 4. Restriction enzyme sites added are underlined in the sequences. Stop codons 
(shown in bold) were positioned downstream of each restriction target. Additional residues were added 5’ 
to the restriction sites to facilitate the complete restriction enzyme cleavage at the ends of PCR 
oligonucleotides. Two different plasmid vectors were used for the construction of the different gene 
constructs. 
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Table 4: Oligonucleotides for DNA-subcloning 
Name Sequence 5' - 3' 
Residues 
cloned 
Tm  
(° C) 
Restriction 
enzyme  
Description 
Forward 
aMBL-
1_pGEX 
gatcGGATCCcaagatctgaaaattcagagttttctgg 
27-288 
66.3 BamHI 
For cloning 
into the 
pGEX-6P-2 
vector 
Reverse 
aMBL-
1_pGEX 
gatcGAATTCttatggccactgcatttcaccttttacc 66.3 EcoRI 
Forward 
aMBL-
2_pGEX 
gatcGGATCCatggggtttgaaaaaacaacatcacagatattatttg
ataatgg 
full 
length, 
FL 
68.1 BamHI 
Reverse 
aMBL-
2_pGEX 
gatcGAATTCttatgttggacagctaaaaatttgttctgtcattaaatc
tacacc 
67.5 EcoRI 
Forward 
aMBL-
1_pETRA 
gatacTCTAGAatgaaattatttaaattatccgcttccgcacttgc 
full 
length, 
FL 
66.2 XbaI 
For cloning 
into the  
pET-RA 
vector 
Reverse 
aMBL-
1_pETRA 
gatcCCATGGttatggccactgcatttcacc 66.8 NcoI 
Forward 
aMBL-
1_pETRA 
gatcTCTAGAatggggtttgaaaaaacaacatcacagatattatttg
ataatgg 
66.5 XbaI 
Reverse 
aMBL-
2_pETRA 
gatcCCATGGttatgttggacagctaaaaatttgttctgtcattaaatc
tacacc 
68.7 NcoI 
Forward 
aMBL-2_DpnI 
gcttcgcatcaggacccagatattatcacc 
full 
length, 
FL 
64.4 DpnI  
For 
mutagenesis 
PCR reaction  
Reverse 
aMBL-2_DpnI 
ggtgataatatctgggtcctgatgcgaagc 64.4 DpnI  
 
- Different recognition sites were underlined in the primer sequences. 
- In reverse primers design, one stop-translation codon (in bold in the sequences) was positioned downstream to the restriction 
target. 
- Nucleotides corresponding to the site-directed mutation are highlighted in red. 
 
The pGEX-6P-2 vector [96] was used to generate in frame fusion proteins with glutathione S-
transferase (GST) at the N-terminal region. This tagging system allows for the removal of the GST carrier 
protein from the fusion protein by enzymatic cleavage with human rhinovirus 3C protease linked to GST 
[97] (see Figure 10).  
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Figure 10: Schematic representation of the pGEX6p-2 vector and the gene sequences corresponding to aMBL-1 and aMBL-2. The 
pGEX6p-2 vector (4900 bp) involves: a glutation-s-transferase tag followed by a 3C-protease target, a multiple cloning site, an 
ampicillin resistance gene and a lacI promotor.  
 
However, this cloning procedure leaves five additional N-terminal residues (Gly, Pro, Leu, Gly and 
Ser). Since the gene encoding aMBL-2 also contained an internal BamHI site at nucleotide position 249 
(See Figure 10), this site had to be eliminated by site directed mutagenesis without changing the amino 
acid sequence. Site directed mutagenesis, removing the BamHI restriction site was achieved by a two step 
PCR amplification procedure. First, blunt ending of PCR fragments was carried out using KOD Hot Start 
DNA Polymerase (Novagen) from genomic DNA and ligated into pCR®-Blunt vector following the protocol 
of The Zero Blunt® PCR Cloning Kit (Invitrogen). Then, a silent mutation (t – c at position 249) was 
introduced using the QuikChangeTM Site Directed Mutagenesis Kit (Stratagene). 
For microbiological assays the pET-RA plasmid [98] was used. This plasmid carries a rifampicin 
resistance cassette, a gene coding for a green fluorescent protein (GFP), and the A. baumannii replication 
origin. It was used to express promoterless genes under control of the CTX-M14 β-lactamase gene 
promoter [98]. 
Gene sequence of aMBL-1:         
BamHIcaagatctgaaaattcagagttttctggctaaaccagagcactttggtgtcacctcaaccttaatagaaggcgacaaagaagttttactggttaat
gcacaattctcaaaatctgaagcattacgtattgctgcaaatattctcgatagcggtaaaacattaaaaactattttcgtaagctatggcgacccggattatt
atttcggcttagatgtatttaaacagtatttcccgaatgtacagatcattgctacgccggaaacagtaaagcatattcaggatactcaagcgcttaaagtta
aatattgggggccacaaatgggtgcaaatgcacctagccaaattattgtgcctcaagcttacactgctaaaactttaaaacttgagaatgagtcaatcgag
attaaaggtaaaaaagagcttacttatttatgggttccttctgcaaaagcagtcgtggggggtattccggtatcttcaggtattcatttatggatggcagata
cacctaaaaccagagatcgtgtggaagttattcaatctttagaaagcatcaaagcactacaacctaaaattgttgtacctgctcatatggttgagggagctc
cacaaggtttagatgctgttaacttttcgattaactatttaaatagttatgaaaaagcagctaaagcaactaaaaatgctactgagctgagcaagctcatgc
agaagcaatacccaacgcttcaaagtgttgatagcttagagctcggcgctaaagtggtaaaaggtgaaatgcagtggccataaEcoRI 
 
Gene sequence of aMBL-2:          
BamHIgggtttgaaaaaacaacatcacagatattatttgataatggcgtacacaaatgtattagttttaccagtttggtcaaaggggaaggcatacaagc
caatcaatttttaattattgatcatgagcgtgctgccgtgatcgacccaggtggtgatttgacctatgttccgttgacaatggaacttaataaatatacgcgcc
ttaaaaatcttgattatgtgatggcttcgcatcaggatccagatattatcacctcaatgccccgctggttagtctataccgatgctaaagtggtggcctcaaa
attatgggcacgttttttacctcacttaaattcatcatttatgagtgagcgtatgaaagggaattgggaagaccgtctgattgagctgcctgatcgtggtcaa
gtgattcaattaggtgaatcgaaacttgtaatcattccagcgcattttctacattcggtgggtaattttcagttttatgatcccgttgctaaaattttattttcgg
gcgatatgggagcatctattgtagatgatgcaagtcagcctctaaaagattttgatagccatgtgatgaaaatgaaagcttttcatcaacgttatatgtgttc
aaataaagttattcgcttatgggtcaacatgattcgtcagatggatattgaaatgattgtccctcagcacggtagtccatttattggtaaagagatgattaat
cagtttttagactggattgaaacattgccatgcggtgtagatttaatgacagaacaaatttttagctgtccaacataaEcoRI 
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Unless indicated otherwise, the amplification reactions were conducted in 50 µl volumes, using 
24 ng of template DNA, 0.25µM of each oligonucleotide primer, dNTPs (0.25 µM each), 1µM MgSO4, 1x 
KOD Polymerase Buffer (see Table 3), and 1µL KOD Hot Start DNA Polymerase. DMSO (Sigma-Aldrich) was 
added to a final concentration of 2% to reduce secondary structures in the DNA and thus increase product 
yield. The samples were transferred to a preheated thermocycler block at 98° C. 
PCR reactions were performed using an Eppendorf Mastercycler with the following program: 
Step Target size 1000 bp Target size 4300 bp 
1. Polymerase activation  95 °C for 2 min 95°C for 2 min 
2. Denature  95 °C for 20 s 95°C for 30 s 
3. Annealing  (Tm - 5 °C) for 10 s (Tm - 5 °C) for 1 min 
4. Extension  68 °C for 15 s 68°C for 9 min 
5. Repeat steps 2–4 20–40 cycles 18 cycles 
6. Final extension 68 °C for 10 min 68°C for 10 min 
 
1.2. AGAROSE GEL ELECTROPHORESIS  
All amplification products were analyzed using agarose gel electrophoresis.  5 µl of each PCR 
reaction was mixed with 1 µl of 6x DNA gel loading buffer Blue/Orange Loading Dye from Promega (0.4 % 
orange G, 0.03 % bromophenol blue, 0.03 % xylene cyanol FF, 15 % Ficoll® 400, 10mM Tris-HCl pH 7.5 and 
50mM EDTA pH 8.0) and loaded in 1% agarose gel in 1x Tris-Acetate- Ethylenediaminetetraacetic acid 
(EDTA) buffer (TAE) (40 mM Tris-Acetate pH 8.3 and 1 mM EDTA). 30 mL gels were stained with 3 μL of 
10,000x SYBR® Safe DNA gel stain. After loading, the electrophoresis was performed at 90 Volts using 1x 
TAE as running buffer. Fragment sizes were determined by comparison with molecular weight standards 
(1 kb DNA ladders, Fermentas). DNA bands were visualized under Ultraviolet (254 nm) light and analyzed 
using the Gel Doc EZ automated imaging system (BIO-RAD).  
1.3. DNA PURIFICATION AND RESTRICTION ENZYME DIGESTION 
PCR products were purified using the QIAquick PCR Purification Kit (Qiagen) while the vectors 
were purified using QIAquick Gel Extraction Kit (Qiagen). Both, amplified DNA fragments and vectors were 
digested with the appropriate restriction enzymes following the supplier´s instructions (NEB). For 
preparative purposes, 2 - 4 µg of DNA were digested with 10 - 15 units of restriction enzyme in a volume 
of 20 - 30 µl of the recommended NEB buffer. After incubation at 37° C for two hours samples were 
electrophoresed on an agarose gel as described for PCR amplification gel purification (see above).  
1.4. DNA LIGATION 
After digestion, in order to prevent recircularization, vectors were dephosphorylated with 1 µl of 
calf intestine phosphatase (CIP, 10U) (NEB) for 30 min at 37 °C [99]. Then, PCR and vector DNA 
concentrations were measured with a UV-visible spectrophotometer Nanodrop ND-1000 (BIO-RAD) from 
the Proteomics and Genomics Facilities at CIB. 
For ligation, approximately 150 ng (3 µl) of purified vector DNA and different ratios of 
vector:insert DNA (1:1, 1:3, 1:5) were mixed in a final volume of 15 µl . Then 20 U/µg of T4 DNA Ligase 
(400 U/µL) (Fermentas) were added. Reactions were incubated overnight at 22 °C and then used for 
transformation. To confirm performance of the reaction a negative control without DNA insert was also 
set for trouble-shooting of the ligation reaction itself. 
 
1.5. DNA MUTAGENESIS 
 The methylated, non-mutated and parental DNA from mutagenesis PCR was first digested, for 1 
h at 37°C, with the restriction enzyme DpnI (NEB) (20 U/µL). The mutagenic insert was confirmed in 1 % 
agarose gel by control digestion with BamHI. 
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1.6.  DNA TRANSFORMATION 
The products of the ligations were confirmed by DNA sequencing (Secugen, CIB) and transformed 
into TG1 electrocompetent cells (Stratagene).  
 
2. Protein expression and purification 
For protein expression in LB media, the plasmids DNAs were transformed into the E. coli 
expression strain Rosetta (DE3) pLysS (Novagen) following the heat shock method. 
2.1. EXPRESSION 
A single colony of the Rosetta transformants was inoculated in 10 mL of LB medium containing 
100 μg/mL ampicillin and 33 μg/mL chloramphenicol and incubated for 10-14 hours at 37 °C in a shaking 
incubator at 250 rpm. The overnight culture was inoculated into 1L of LB medium supplemented with the 
same antibiotics. The cultures were grown at 37 °C in a shaking air incubator at 250 rpm until the optical 
density at 600 nm (OD600nm) reached 0.6 – 0.8. Protein expression was induced by addition of Isopropyl -
D-1-thiogalactopyranoside (IPTG) (Calbiochem) to the culture to a final concentration of 1 mM and then 
incubated for further 4 hours at 37 °C. Cell cultures were harvested by centrifugation (6000 xg, 20 min, 4 
°C). Cell pellets were resuspended in 30 mL of lysis buffer (PBS buffer supplemented with 0.5 % Tween-20 
(BIO-RAD)). The cells were sonicated in a Misonix S4000 Sonicator following a single sonication protocol: 
1. Amplitude: 30; Time: 1 min 30 s; Intervals: 2 s ON, 1 s OFF. 
2. Amplitude: 40; Time: 2 min; Intervals: 2 s ON, 1 s OFF. 
3. Amplitude: 50; Time: 2 min; Intervals: 2 s ON, 1 s OFF. 
Insoluble material was pelleted at 30000 rpm using a 60Ti rotor (Beckman) for 30 min at 4 °C and 
the supernatant was collected and filtered with a 0.45 µm syringe filter (Sartorius Stedim Biotech). 
 
2.2. PROTEIN PURIFICATION OF GST-TAGGED PROTEINS 
Before loading the supernatant containing the soluble GST-tagged proteins, a GST Trap HP 5 mL 
column (GE Healthcare-Amersham Biosciences) was connected to a single-channel peristaltic pump that 
was extensively washed with water and finally equilibrated with the PBS binding buffer supplemented 
with 1mM Dithiothreitol (DTT) (Sigma). After loading the sample, the column was washed with 30 mL of 
binding buffer to reduce non-specific binding of other proteins. 
Bound proteins were then subjected to an on-column cleavage of the fusion GST protein with 200 
μg of 3C protease with GST-tag [97]. For that, the binding buffer was changed to the cleavage buffer (50 
mM Tris-HCl (Merck), 150 mM NaCl (Merck), 1 mM DTT (Sigma) and adjusted to pH 7.5). 3C protease was 
diluted in this buffer (5 mL total volume) and manually injected into the column. Following injection, the 
column was closed, sealed and incubated overnight at 4 °C. 
The target protein was eluted from the column with 6 column volumes of the cleavage buffer. A 
final 10 column volumes wash with elution buffer (50 mM Tris-HCl and 10 mM L-glutathione reduced 
(GSH), adjusted to pH 8.0) was applied to complete elution of the GST-tag, the uncleaved protein and the 
GST-3C protease. The different elute batch fractions were analyzed by 15 % SDS-PAGE and pure fractions 
were concentrated by ultracentrifugation with AMICON ULTRA-15 10KDa (Millipore) for the next step of 
purification. 
The concentrated fractions were then loaded into a HiPrep 16/60 Sephacryl S-100 HR prepacked 
column (GE Healthcare-Amersham Biosciences) connected to an ÄKTAprime™ (GE Healthcare-Amersham 
Biosciences). The column was equilibrated with cleavage buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM DTT 
adjusted to pH 7.5) at room temperature with a flow rate of 0.5 mL/min.  The pooled peak fractions were 
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concentrated by ultracentrifugation to a final concentration of 20 mg/mL for the following crystallization 
trials. 
2.3. EXPRESSION OF SEMET-LABELED PROTEINS   
To solve macromolecular structures, phases can be determined experimentally using methods 
that rely on finding the positions of a few special anomalously scattering atoms. Protein expression in 
suitable host and growth media allows incorporation of Se-Met for SAD or MAD phasing experiments 
[100].  
In this project, a method was used, which is based on the inhibition of the methionine 
biosynthesis, where a high incorporation of SeMet (> 90%) in the labeled protein can be observed. 
Inhibition of this metabolic pathway can be achieved by the use of high concentrations of Ile, Leu, Phe, Lys 
and Thr [101]. 
The procedure was as follows: From E. coli culture glycerol stocks: [pGEX6p-2-(aMBL-1)] and 
[pGEX6p-2-(aMBL-2)], were inoculated  in 20 mL of LB medium containing 100 μg/mL ampicillin and 33 
μg/mL chloramphenicol and incubated overnight at 37 °C in a shaking incubator. Then cells were 
inoculated into 1L of LB medium and grown until an OD600nm of 0.6-0.8 was reached. Cells were then 
harvested at 6000 x g for 10 min at 4 °C. The pellet was washed with M9 medium and after centrifugation, 
resuspended in 1L of enriched M9 medium with the inhibitory cocktail of amino acids. SeMet (50 mg/1L) 
was added to the medium 15 min before induction.  
The expression and protein purification were performed as described for the unlabeled protein. 
The degree of Se incorporation was checked by mass spectrometry [102]. 
Used medium composition (All the solutions were autoclaved except for the vitamin stock and glucose which should be sterile 
filtered using a 0.2 μm syringe filter): 
– Enriched M9 medium (1X): M9 medium 1X, Ca/Mg solution, 10 mg/L B1 vitamin and 0.4 % Glucose. 
– M9 medium (1X): 8.8 g/L Na2HPO4-2H2O; 3 g/L KH2PO4; 0.5 g/L NaCl y 1 g/L NH4Cl. 
– Ca/Mg solution (for 1 L culture): 14.7 mg/L CaCl2-2H2O and 246 mg/L MgSO4-7H2O. 
– Amino acids cocktail (for 1 L culture): 100 mg Lysine; 100 mg Threonine; 100 mg Phenylalanine; 50 mg Leucine; 50 mg 
Isoleucine and 50 mg Valine. 
 
3. Biophysical and Biochemical Protein Characterization  
3.1. ANALYTICAL GEL FILTRATION  
Gel filtration provides a mean for the estimation of the molecular weight of proteins under study. 
It could be determined by comparing the retention volume parameter (Vr) with the values obtained for 
several known calibration standards. 
The samples were injected onto a calibrated gel filtration column Sephadex200 10/300 GL column 
(GE Healthcare) at room temperature and with a flow rate of 0.5 mL/min. The column was previously 
equilibrated in buffer, containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM DTT. The peak fractions as 
detected at 280 nm were analyzed by SDS/PAGE. 
Calibration of the Sephadex200 10/300 GL column was carried out using the following standards: 
Blue Dextran (2000 KDa), Ferritin (450 KDa), Catalase (240 KDa), Aldolase (158 KDa), Bovine Serum 
Albumin (BSA) (68 KDa), Albumin egg (45 KDa), Chymotrypsinogen A (25 KDa) and Cytochrome C (13 KDa). 
These lyophilized proteins were dissolved in the storage buffer of the target protein (50 mM Tris-HCl, pH 
7.5, 150 mM NaCl, 1 mM DTT) at concentrations recommended by the manufacturer (Boehringer). 
 
3.2. ANALYTICAL ULTRACENTRIFUGATION 
These experiments were carried out by the Analytical Ultracentrifugation Facility at CIB (Madrid), 
on an Optima XL-I analytical ultracentrifuge (Beckman-Coulter) equipped with UV-visible absorbance 
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optics. Experiments were conducted at 20 °C using an AnTi50 rotor and Epon-charcoal standard double 
sector centerpieces (12 mm optical path length). Absorbance scans were taken at the appropriate 
wavelength (280–295 nm).  
Two different experiments were carried out: Sedimentation velocity (SV) and sedimentation 
equilibrium (SE). Protein samples at 0.3, 0.9 and 2 mg/mL were pre-cleared at 16.000 x g beforehand.  
SV experiments were performed at 48 krpm using 400 µL samples in buffer consisting of 50 mM 
Tris-HCl pH 7.5, 150 mM NaCl, 0.3 mM DTT. The resulting concentration gradient of material in the cell as 
a function of time and radial position was monitored by absorbance at 280 nm. Differential sedimentation 
coefficient distributions (c(s)) were calculated by least-squares boundary modeling of sedimentation 
velocity data using SedFit software (Version 12.1b) as described [103]. The calculated frictional ratios were 
used to transform the c(s) distribution into the corresponding molecular mass distribution [104-105]. 
For SE experiments, short column (85 µL) runs were carried out at multiple speeds (9 and 11 
krpm) by taking absorbance scans at the different wavelengths depending on sample concentration: for 
AMBL-1 at 0.3 and 2 mg/mL (was to 280 nm) and at 0.9 mg/ml (290 nm), for AMBL-2 at 0.3 mg/ml (280 
nm), at 0.9 mg/ml (295 nm) and 2 mg/ml (290 nm). After the equilibrium scans, a high-speed 
centrifugation run at 45 krpm was done to estimate the corresponding baseline offsets. 
The weight-average buoyant molecular weight of both proteins was calculated using the Hetero-
Analysis program (Version 1.1.44) [106]. The molecular weight of the proteins was determined from the 
experimental buoyant masses using the values of 0.7486 cm3/g and 1.00601 g/cm3 as the partial specific 
volume and density, respectively. 
 
3.3. MASS SPECTROMETRY 
These experiments were performed on an Autoflex III MALDI-TOF-TOF instrument (Bruker 
Daltonics, Bremen, Germany) with a smartbeam laser by the Proteomic platform at INIBIC-CHUAC (A 
Coruña). The spectra were acquired using a laser power just above the ionization threshold. Samples were 
analyzed in the linear mode using positive ion detection with delayed extraction of ions. 
Through matrix-assisted laser desorption ionization (MALDI) peptide mass fingerprinting, mass 
spectrometry in tandem (MS/MS analysis) and database searching were performed. Samples were 
analyzed in a MALDI-TOF/TOF instrument (4800 ABSciex) and 4000 series Explorer v.4.2 software was used 
to generate the spectra and peak list. Fragmentation spectra were acquired by selecting the 20 most 
abundant ions of each MALDI-TOF (time-of-flight mass spectrometer) peptide mass map (excluding trypsin 
autolytic peptides and other background ions). For database queries and protein identification, the 
monoisotopic peptide mass fingerprinting data obtained from MS and the amino acid sequence tag 
obtained from each peptide fragmentation in MS/MS analyses were used to search for protein candidates 
using ProteinPilot 3.0 software (ABSciex). The search for tandem MS spectra was performed in last release 
of Uniprot-Swisprot database for Acinetobacter baumannii. 
Molecular weight analysis of derived protein (SeMet labeled protein) was carried out by MS-
MALDI TOF at the Proteomics and Genomics Facilities at CIB (Madrid). Concentration protein was 10.8 
mg/ml in 50mM Tris-HCl pH 7.5, 150mM NaCl and 1mM DTT buffer. 
 
4. Protein crystallization 
Macromolecular structure determination by X-rays relies on the availability of single crystals. 
Producing high-quality crystals is not trivial and the process can be long and frustrating because many 
parameters may have to be tested and optimized to find the optimal conditions. Crystallization of 
macromolecules is the major bottleneck in protein structure determination. There is no single way to 
efficiently predict under what specific conditions a protein will form single crystals. Crystallization is a 
multi-parametric process involving three main steps: nucleation, growth and cessation of growth. Crystal 
growth occurs from a supersaturated solution as a result of homogeneous nucleation. If the protein 
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concentration does not reach the required supersaturated state, no nucleation event occurs and the 
crystallization drop remains clear (see Figure 11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: The sketch on the left illustrates the principle of the sitting-drop vapour diffusion technique. From the resulting starting 
drop (S, purple), water vapor diffuses into the precipitation cocktail reservoir and both protein and solute concentration in the 
drop increase. Once the region of spontaneous nucleation is reached (Labile), crystallization nuclei can form (1) and a crystal may 
start to grow. While the crystal grows (2,3), the solution depletes in protein, and a few of the initial crystals continue to grow large 
in the growth region of the phase diagram (Metastable). Once the crystals are in equilibrium with the saturated protein solution 
(4) they have reached their final size and growth stops. The diagram is divided into four zones: Stable: undersaturated where 
crystallization is not possible; Metastable: supersaturated where nuclei cannot form but crystals from seeds can grow; Labile: 
supersaturated where crystallization can occur; Precipitation. 
Vapour diffusion is the most commonly employed technique for protein crystallization. The 
droplet containing a solution of the protein (buffered at a given pH), the precipitating agent and additives 
is allowed to equilibrate in a closed system with the reservoir solution at a higher precipitant 
concentration. To find the optimal crystallization conditions, hundreds to over a thousand of different 
solutions are screened in order to get a suitable condition that yield diffracting crystals.  
The first approach to search for initial crystallization conditions was based on the sparse matrix 
formulation [107] using the sitting drop vapour diffusion technique with multidimensional commercial 
crystallization kits from Emerald Bioscience (Wizard I - II - III), Jena Bioscience (JBScreen 1 - 10) and Axygen 
Bioscience (CUSTOM I - V).  Crystallization drops were prepared with a Cartesian HoneyBee X8 nanolitre-
dispensing robot (Genomic Solutions) using the MRC 96-well sitting drop plates (Molecular Dimensions). 
The wells were filled up with 50 μL of the appropriate reservoir condition. Subsequently, the robot 
dispensed 200 nL of protein plus 200 nL of the reservoir solution. These experiments were performed at 
two different protein concentrations, aMBL-1: 30 mg/mL and 10 mg/mL; aMBL-2: 20 mg/mL and 10 
mg/mL. The plates were sealed and stored at room temperature (22 °C). 
The progress of the initial crystallization setups was monitored under a microscope (Leica) 
equipped with a polarization filter. If promising crystalline material is obtained during the initial screening, 
the next step was to fine-tune the initial crystallization setups in order to get the best conditions to obtain 
bigger and better diffracting crystals. 
Optimization was carried out with a finer adjustment of the protein and/or precipitant 
concentrations, or changes in the pH. Furthermore, the rate at which supersaturation occurs may greatly 
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affect crystal growth. Because of this, we have increased the size of the droplets (1 μL of protein + 1 μL of 
reservoir condition) dispensed manually in the 24-well crystallization plates (Cryschem plates from 
Hampton). Crystals were grown at room temperature (22 °C). 
In some cases, crystals were adhered to the well surface making it very difficult to manipulate. To 
avoid this phenomenon we added Silicon Oil (Molecular Dimensions) to the bottom of the well and left for 
drying at 70 °C for 20 minutes. Then, drops were set up. 
 
4.1. CRYOGENIC PROTECTION OF THE CRYSTALS 
Radiation damage in protein crystals upon exposure to high X-ray energies is mainly produced by 
free radicals. Among effects of radiation damage in crystals are the decreasing of the diffraction intensity 
and resolution. In some cases, the crystal completely stops diffracting. Cryocooling of protein crystals into 
liquid nitrogen is usually employed to reduce radiation damage during X-ray data collection [108].   
Mounting a crystal for cryoprotection involves suspending it by surface tension in an appropriate 
cryobuffer within a nylon loop and then flash-cooling in liquid nitrogen. In flash-cooling the temperature 
of the crystal is lowered as rapidly as possible in order to suppress crystalline ice formation. The protein 
crystal resides into a clear, rigid and vitreous glass. However, ice will form in most solutions used for 
crystals grow. It is necessary to suppress this tendency by addition of cryoprotectants to the solutions. 
Cryoagents help to form vitrified water rather than crystalline ice. Although there is quite a choice of 
cryoprotectant compounds, we used polyethylene glycol 400 (PEG400) (see Table 5) at 5-20 % 
concentration as cryoagent. 
 
5. Structure determination 
5.1. X-RAY DIFFRACTION AND ANOMALOUS SCATTERING 
X-ray crystallography is one of the most important techniques to get the structure of biological 
macromolecules at atomic resolution. The X-rays are scattered in all directions by the electrons contained 
in the protein crystal with a magnitude proportional to the number of scatterers.  
In a diffraction experiment, the position and intensities of waves scattered from planes (denoted 
by hkl) in the crystal are measured. Intensity is proportional to the sum of the atomic numbers of all the 
atoms in the crystal structure and from each one it is calculated a scalar structure factor amplitude, Fh, but 
the phase angle, αh of the complex structure factor, Fh is missing in this measurement (Fh = Fh∙ exp(iαh)). 
This is the main obstacle in crystal structure analysis: the phase problem. 
Supplying the phases for each reflection is possible through additional experimental phasing 
(MIR, MAD, SAD) or by molecular replacement when a structure or part of the structural model is known. 
Once the phase problem is solved, the electron density within the crystal can be derived from the 
diffraction pattern through a mathematical method, the Fourier transform, which allows to calculate the 
density at every point in the space: 
 
In this final form of the density summation at a grid point x (x,y,z), the Fourier coefficients 
Fh∙exp(i αh) explicitly include both the structure factor amplitude Fh and its associated phase, αh. As the 
physical source of diffraction was the scattering of X-ray photons by the electrons distributed around the 
atoms of the molecules into the crystal, this mathematical inversion of the diffraction process will deliver 
the electron density distribution within the unit cell of the crystal. 
Resonance between beams of X-ray waves and electronic transitions from bound atomic orbital 
leads to a phenomenon known as anomalous scattering. If there are anomalous scatterers in the crystal it 
is possible to determine the crystal structure by the MAD (multiple anomalous dispersion) or SAD (single 
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anomalous dispersion) techniques.  A typical MAD experiment is performed at three different 
wavelengths, at minimum f’ and maximum f’’ of the absorption edge of the anomalous scatterer, and at a 
distant wavelength (remote) where the anomalous signal is small. In some cases, data collected at one 
wavelength (SAD) were enough to determine phases. It could be demonstrated, that good phases 
estimates can be obtained by a more accurate measurement of diffraction intensities.  
 
5.2. DATA COLLECTION 
The data were collected using synchrotron radiation at the ESRF Structural Biology Beamlines 
(ID14-1 and ID14-4) using the MXCuBE (“MX Customised Beamline Environment”) control module [108]. 
Frames were taken when the crystal was rotated around itself in small increments (1°) while it was 
exposed to X-rays and the reflections were recorded using a high-resolution 2D detector: the X-ray 
sensitive charge-coupled device (CCD) detector (ADSC). The appropiate wavelength was selected by a 
multilayer mirror. The structure determination was achieved by multiple wavelength anomalous 
dispersion (MAD) experiment for aMBL-1 [109] and by the single-wavelength anomalous diffraction (SAD) 
phasing method for aMBL-2 using energy tunable synchrotron radiation and selenomethionine (SeMet) 
recombinant proteins. The first step in designing the MAD or SAD experiments was to select specific 
wavelengths from the broad spectrum of energies that optimize the anomalous signal for the selected 
atom (K-absorption edge of Selenium). Since the scattering factors that determine these signals depend 
on the initially unknown chemical environment of the site and on the energy resolution of the beam, an X-
ray fluorescence spectrum from the crystal across the heavy atom absorption edge is required. X-ray 
fluorescence spectra were measured by an XFlash fluorescence detector (Rontec) to provide the necessary 
information for finding f’ and f’’ at the appropiate wavelength for measuring anomalous diffraction data.  
Complete MAD data sets were collected to 2.39 Ǻ at three different wavelengths (see Table 5). To 
avoid radiation damage, the strategy was to collect under similar circumstances for a given reflection the 
appropiate Bijvoet mate. Thus, after each rotation increment, the φ-axis is rotated quickly by 180º for 
inverse-beam measurements [110]. This reduces potential difficulty in the later scaling stage, when 
reflections from temporally distant exposures need to be combined and merged into a single data set.  
Table 5: Data collection 
 aMBL-1 aMBL-2 
 
Native 
Monoclinic 
Native 
Orthorhombic 
Se_pk Se_ip Se_rm Native Se_pk 
X-ray source  ID14.4 ID14.1 ID14.4 ID14.4 
X-ray detector 
Q315r  
ADSC CCD 
Q210 ADSC 
CCD 
Q315r ADSC CCD 
Q315r  
ADSC CCD 
Wavelength (Å) 0.9770 0.9334 0.9794 0.9795 0.9770 0.9393 0.9794 
Energy (keV) 12.69 13.28 12.66 12.66 12.69 13.2 12.66 
Beam transmission (%) 41 100 74 5 41 
Detector distance (mm) 255.31 166.52 290.7 340.91 376.4 
Cryo condition 15 % PEG400 5 % PEG400 15 % PEG400 15 % PEG400 
 
 
5.3. DATA PROCESSING 
After the data are collected, one needs to index each of the reflections in all the images by 
assigning each diffraction spot to its corresponding HKL value along with its intensity (or amplitude, F) and 
the error (). The indexing, processing and data reduction involves several steps that can be summarized 
as follows:  
1. Visual inspection and preliminary analysis of the unprocessed diffraction images by 
MOSFLM [111], a graphical user interface for diffraction data. 
2. Indexing of the diffraction data. This means identifying the dimensions of the unit cell.  
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3. Refinement of the crystal and detector parameters to minimize the discrepancies 
between observed and calculated spot positions in the data images. 
4. Study of the crystal symmetry and determination of the space group.  
5. Integration of the diffraction intensities; partial reflections extended over multiple 
frames are combined onto single reflections. 
6. Crystal parameters post-refinement using all the data acquired. 
7. Scale the indexed data set: equivalent reflections (symmetry related) will be merged and 
listed just once along with the error associated with all the equivalent measurements. 
There are a variety of programs available to carry out the data processing. Native datasets were 
integrated and scaled using the programs MOSFLM [111] and SCALA from the CCP4 suite [112-114]. 
Structure factor amplitudes were derived from the intensities using the program TRUNCATE [115] from 
the CCP4 suite. Selenomethionine data were processed with the X-ray Detector Software (XDS) package 
[116]. The HKL files (an unmerged XDS ASCII file) obtained from the XDS package included the inferred 
crystal symmetry and metrics, and a list of corrected integrated intensities of the reflections. XSCALE [117] 
placed it on a common scale, optionally merged them into one or several sets of unique reflections and 
reported their completeness and the quality of the integrated intensities. XDSCONV [115] was used to 
convert these reflection data files into standard MTZ format, as it is required by various software packages 
for crystal structure determination. 
 
5.4. CRYSTALLOGRAPHIC COMPUTING PROGRAMS AND MODEL REFINEMENT 
For the rest of crystallographic analysis, it was very important to index accurately the space group 
which the crystals belong to. That was carried out by Pointless [118] and Reindex [112], both from the 
CCP4 suite for both kinds of datasets. 
Heavy atom positions were determined using SHELX [119]. AutoSHARP (Statistical Heavy-Atom 
Refinement and Phasing) [120] was used for MAD/SAD experiments, using three wavelengths (peak, 
inflection and remote) for obtaining initial phases for aMBL-1 and on a single data set (peak wavelength) 
for aMBL-2.  
In Phenix suite (Python-based Hierarchical ENvironment for Integrated Xtallography [121]), 
phases found by AutoSHARP were refined using AutoSol, rendering a first model for both new structures 
of this project. The resulting three-dimensional structures were extended through a combination of 
manual building in Coot [122] with alternating refinement cycles in the reciprocal space with the program 
phenix.refine. 
The structure determination and refinement procedures might have biases that prone the 
structure models to systematic errors. Therefore, it is necessary to validate the quality of the final model. 
There are a variety of tools available that measure the deviation of the geometric and conformational 
parameters of the model from those of other small molecules or high-quality structures of other 
macromolecules. After the last refinement was completed, the validation of the final models was 
performed with all available tools in Coot and the derived software from the Molprobity web server [123].  
The program PyMol [124] (http://www.pymol.org) was used for the 3D visualization and 
representation of both solved structures. 
 
6. Functional assays 
6.1. ENZYMATIC ACTIVITY 
In accordance with studying the catalytic behavior of aMBL-1 and aMBL-2, enzymatic activity 
experiments were performed against a set of general chromogenic substrates. 
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By the application of general enzymatic screens and substrate profiling [125], glioxalase II, 
phosphatase, phosphodiesterase, esterase and thioesterase activities were tested for aMBL-1. Two 
different protein samples were used in these assays: aMBL-1 produced in LB medium and AMBL-1 
produced in M9 medium. Both samples were applied at 30 mg/ml concentration and assays were 
performed at 37° C. The screens were inspected by eye or in a spectrophotometer. 
Table 6: Activity tests with general chromogenic substrates  
Enzyme Type Reaction Mixture OD (nm) 
Β-lactamase 1x PBS, 2mM BSA, 2 mM nitrocefin 490 
Glioxalase II 100 mM MOPS (pH 7.2), 900 µM S-D-lactoylglutathione, 200 µM DTNB 412 
Phosphatase 50 mM HEPES (pH 7.5), 5 mM Mg2+, 0.5 mM Mn2+, 4 mM pNPP 405 
PDE/Nuclease 50 mM Tricine (pH 8.5), 5 mM Mg2+, 0.5 mM Mn2+, 0.83 mM bis-pNPP 405 
Esterase 50 mM Tris (pH 8.0), 0.4% Triton X-100, 1 mM pNP-palmitate 410 
Thioesterase 50 mM HEPES (pH 7.5), 0.4% Triton X-100, 1mM DTNB, 1mM palmitoyl-CoA 412 
 
6.1.1. ANALYSIS OF β-LACTAMASE ACTIVITY 
The hidrolytic activity of aMBL-2 protein was only tested against nitrocefin, a chromophoric 
cephalosporin without therapeutic utility but which undergoes intense spectroscopic changes upon 
hydrolysis. These kinetic experiments study the hydrolysis and accumulation of a ring opened, anionic 
intermediate of nitrocefin [126-127]. 
β-lactamases and β-lactam antibiotics interact to form a noncovalent enzyme-substrate complex. 
After β-lactam antibiotic is acylated, a strategically water molecule positioned on the active site 
hydrolyzes the acylated substrate [128]. In this manner, the β-lactamase is regenerated and can inactivate 
additional β-lactam molecules.  
Competitive inhibition assays were carried out when a tested inhibitor competes with the 
substrate for the substrate binding site. For reversible inhibition, the reaction can be described as was 
shown above in equation 1, where S represents the (very) slowly hydrolyzed substrate. An equilibrium 
constant, Ki, can be calculated from the pre steady state rate constants, k-1/k1, and yields an estimate of 
affinity.  
The 50% inhibitory concentration (IC50) measures the amount of inhibitor required to decrease 
enzyme activity to 50% of its uninhibited velocity. While an IC50 can reflect an inhibitor’s affinity or 
kcat/kinact ratio, these parameters are not always congruent; e.g., an inhibitor can have a very poor 
“affinity” and acylate the enzyme slowly but still yield a low IC50 because of very low deacylation rates. 
Kinetic experiments were performed with pure proteins (aMBL-1 at 33 mg/mL and aMBL-2 at 9 
mg/mL) at 25 °C using a Nicolete Evolution 300 spectrophotometer (Thermo Electron Corporation, 
Waltham, MA) with quartz cuvettes of optical path lengths of 1 cm. The tests were each repeated three 
times in phosphate-buffered saline (PBS) with 20 µg/mL bovine serum albumin (BSA). The kinetic 
parameters kcat (Catalitic constant), Km (Michaelis-Menten constant), and kcat/Km (efficacy catalytic 
ratio) were studied for the antibiotics ampicillin, piperacillin, cefuroxime, ceftazidime and imipenem. The 
Km values were calculated as Ki values in competitive assays with nitrocefin (Oxoid Ltd.) as the substrate. 
The Vmax was calculated by considering an antibiotic concentration six times the Km and by use of the 
Michaelis-Menten equation, as previously described [129]. 
 
6.1.2. ANALYSIS OF GLIOXALASE II ACTIVITY 
1 mL volumes of 100 mM 3-(N-morpholino)propanesulfonic acid (MOPS) pH 7.2 containing 900 
µM S-D-lactoylglutathione (Sigma), 200 µM 5, 50 dithiobis-2-nitrobenzoate (DTNB) (Sigma) were 
monitored for the increase in absorbance at 412 nm for 1 min. Glutathione produced by the action of 
enzyme reduces the DTNB to form the yellow-colored product 5-thio-2-nitrobenzoic acid (TNB). The 
enzyme reactions were initiated by the addition of enzyme and were carried out at 37 °C. 
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6.1.3. ANALYSIS OF PHOSPHATASE ACTIVITY 
First, appropriate serial dilutions of AMBL-1 samples were made with PA Assay Buffer (50 mM 
HEPES (pH 7.5), 5 mM Mg2+, 0.5 mM Mn2+). Then, 50μl diluted test samples were transferred in a 96-well 
plate as well as 50μl PA Assay Buffer without enzyme for blank wells. The reaction started with the 
addition of 50μl PA Substrate (50 mM HEPES (pH 7.5), 5 mM Mg2+, 0.5 mM Mn2+, 4 mM p-nitrophenyl 
phosphate (pNPP)) to each well. After 10-30 minutes of incubation at 37 °C, 50 μl Stop Solution (3M 
NaOH) was added to each well to stop the reaction. The phosphatases remove the phosphate group to 
generate p-nitrophenol, which is deprotonated under alkaline conditions to produce p-nitrophenolate that 
has strong absorption at 405nm. 
6.1.4. ANALYSIS OF PHOSPHODIESTERASE ACTIVITY 
Experiments were performed in 50 mM Tricine, pH 8.5, and 2 mM MnCl2. Bis-pNPP hydrolysis 
was determined following the absorption of p-nitrophenolate at 405 nm. 
Other potential phosphodiesterase substrates as double stranded DNA (λ DNA), single stranded 
DNA (M13mp8 phage DNA) and lineal 1000 bp DNA were tested by agarose gel electrophoresis stained 
with ethidium bromide. Negative controls of DNA degradation included incubation with reaction buffer 
supplemented with EDTA or ATP. 
6.1.5. ANALYSIS OF ESTERASE ACTIVITY 
A stock solutions of 100–250 mM p-nitrophenyl ester was prepared in CH2Cl2. Immediately prior 
to initiation of the assay, 20 µL of the stock was diluted into 10 mL of buffer containing 20 mM Tris–HCl 
(pH 8.0), 150 mM NaCl, and 0.01% Triton X-100 while vortexing. Protein samples of up to 20 µL are 
incubated with 0.2 mL substrate solution in 96-well clear microtiter plates. During the incubation period at 
37 °C (up to 30 min), the liberation of p-nitrophenol is measured as the increase in absorbance at 410 nm 
in an ultraviolet–visible spectrophotometer against a blank without enzyme. 
6.1.6. ANALYSIS OF THIOESTERASE ACTIVITY 
The acyl-CoA thioesterase activity of purified AMBL-1 was measured using DTNB. Hydrolysis of 
acyl-CoA molecules leads to a rapid reaction between DTNB and CoA to form TNB, which absorbs light at 
412 nm. Reactions were carried out in 200 μl volumes within the wells of 96-well Nunc plates (Fisher 
Scientific). The substrate palmitoyl-CoA was prepared as 10 mM stock solutions in water. 
Appropriate volumes were mixed with reaction buffer to achieve final concentrations in 50 mM 
HEPES (pH 7.5), 0.4% Triton X-100 and 1mM DTNB. Then, 33 mg of AMBL-1 were added to initiate acyl-
CoA hydrolysis. Plates were immediately loaded into a temperature-controlled SpectraMax M5 microplate 
reader (Molecular Devices), mixed for 5 s and absorbance readings at 412 nm were taken at 1 min 
intervals for up to 60 min. Incubation without substrate served as a control to determine background 
degradation of DTNB. 
6.2. ANTIBIOTIC SUSCEPTIBILITY TEST 
Antibiotic susceptibility experiments are used to confirm bacteria resistance against antibiotics 
and to determine the MIC (Minimum Inhibitory Concentration) values of a strain, establishing the lowest 
concentration of an antibiotic inhibiting visible growth of bacteria. 
These quantitative methods were executed with two different strains: A. baumannii ATCC 17978 
and Acinetobacter sp. strain ADP1 both harboring the proteins under study subcloned in the pETRA vector. 
As a negative control an empty pETRA vector was used.  
MICs breakpoints of several antibiotics were determine by two different methods: standard disk 
diffusion method (Becton, Dickinson and Company) and epsilometer test (E-test) (AB Biodisk) on Mueller-
Hinton agar at 37 °C following the manufacturer´s criteria.  After Acinetobacter bacteria suspensions were 
adjusted to a turbidity equivalent to a 0.5 McFarland standard, approximately 5x105 CFU/mL of these 
suspensions was inoculated onto agar plates using sterile cotton-tipped swabs to produce a confluent 
lawn of bacterial growth. When the inoculum on the plates was dry, some antibiotic disks were distributed 
following the disk diffusion method to determine the zone diameter breakpoints. On the other hand, 
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some of these inoculated plates were used to determine MIC breakpoints by Etest, which are thin plastic 
strips covered with a continuous antimicrobial gradient of an antibiotic on one side and a number scale on 
the other. When they are placed in an inoculated plate, the antibiotic is immediately released into the 
agar forming a stable continuous gradient of antibiotic concentrations underneath the strip. After 16-18 h 
of incubation at 37°C, bacterial growth has become visible and an ellipse formed inhibition zone is seen 
centered along the strip. MIC value is read from the scale (μg/ml) where the ellipse edge intersects the 
strip. MIC measures are accurate and reproducible.  
The different used disks and Etest were: 10 μg ampicillin (AM10), 10 μg penicillin (P10), 100 μg 
piperacillin (PIP100), 110 μg piperacillin-tazobactam (TZP110), 30 μg cephalothin (CF30), 30 μg cefoxitin 
(FOX30), 30 μg cefotaxime (CTX30), 30 μg ceftazidime (CAZ30), 30 μg cefepime (FEP30), 10 μg meropenem 
(MEM10), 10 μg imipenem (IMP10), 30 μg aztreonam (ATM30), 30 μg amoxicillin-clavulanic acid (AMC30) and 
10 μg colistin (CL10). The MIC breakpoints and the zone diameter breakpoints of each antimicrobial agent 
were determined according to the recommendations of Clinical and Laboratory Standards Institute [130].  
These preliminary MICs values obtained from on plates methods were tuned by broth 
microdilution method [130]. The corresponded Acinetobacter inoculums of 5x105 CFU/mL were incubated 
for 24 to 48 h at 37 °C in LB medium. As the end point, the lowest concentration of the compound that 
completely inhibited growth was recorded as the MIC. 
The used antibiotics for this assay were purchased from Sigma-Aldrich: ampicillin, penicillin, 
piperacillin, cephalothin, cefoxitin, cefuroxime and aztreonam. Cefepime was obtained from Sigma-
Genosys Ltd. (United Kingdom) and imipenem was obtained from Merck Sharp and Dohme (Madrid, 
Spain).  
The hydrolytic activity against antibiotics was also determined by an adaptation of the Masuda 
method. Over a Mueller-Hinton agar plate, an inoculum of E. coli DH5α cells/ml 0.5 McFarland was 
extended and several disks were placed around an ampicillin disk in the middle (AM10, 10µg). Different 
disks contain: OXA (45µg), (+) control (enzyme with well-known β-lactamase activity), BSA (45µg), (-) 
control (enzyme without β-lactamase activity) and the target proteins (45 µg). It could be observed that 
the halo of growth around the ampicillin disk was deformed by bacteria which could incorporate the 
protein with hydrolytic activity.   
 
6.2.1 QUANTITATIVE RT-PCR 
To confirm increased expression of the target genes, the original A. baumannii ATCC 17978 strain 
as well as A. baumannii ATCC 17978 with different constructions in pE-TRA vector were used in a reverse-
transcriptase PCR (RT–PCR) to determine the over-expression of target genes relative to the house-
keeping gene gyrB from A. baumannii ATCC 17978 which codes for two of the four subunits of the 
bacterial DNA gyrase enzyme. Total RNA was extracted by High Pure RNA Isolation kit (ROCHE) according 
to the manufacturer’s instructions. RNA samples were tested by performing PCR without Reverse 
Transcriptase confirmed the absence of DNA. The concentration and integrity of the RNA were 
determined by measuring the OD260/230 and OD260/280 as well as by 1% agarose gel electrophoresis. A 
total of 50 ng of RNA was used in the target gene studies. 
Real-time RT-PCR analysis of genes expression was performed for aMBL-1 and aMBL-2 and gyrB 
(housekeeping) for triplicate using specific internal oligonucleotide primers and Taqman probe UPL 
(Universal ProbeLibrary), ROCHE. The concentrations of them were adjusted to give amplification 
efficiencies of 90 to 110%.  
Gene expression was normalized versus that of gyrB in the same strain and calibrated relative to 
ATCC 17978 A.baumannii, which was assigned a value of 1.0. 
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Primers for RT-PCR: 
aMBL-1 (full length): Probe gatggcag 
Forward: 5’- gggtattccggtatcttcagg- 3´ 
Reverse: 5’- ttccacacgatctctggtttt- 3´ 
aMBL-2 (full length): Probe gctgcctg 
Forward: 5’- gaattgggaagaccgtctga - 3´ 
Reverse: 5’- tcacctaattgaatcacttgacca - 3´ 
Housekeeping gene (gyrB) tggtggaa 
Forward: 5’- cattcttcttccgtcaaatgc- 3´ 
Reverse: 5’- tattgcacagccacctttgt- 3´ 
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RESULTS 
 III. RESULTS 
CHAPTER 1:                                                                                                                                aMBL-1 
 
1. Sequence analysis 
In an attempt to solve the structure and to understand the function of this uncharacterized 
protein found in the genome of Acinetobacter baumannii, bioinformatics tools were used to explore the 
presence of conserved domains in the sequence as well as for protein family classification.  
3.1.1. SEQUENCE ANALYSIS 
The ABAYE3862 gene encodes a protein, aMBL-1 (http://www.ncbi.nlm.nih.gov/gene/6002746) 
classified by the InterPro web server [131] belonging to the metallo-β-lactamase superfamily, containing a 
β-lactamase domain and a signal peptide in its sequence. Also, the program HHpred [132] found a number 
of related proteins, of which the eight closest homologues proteins shared the typical αβ/βα metallo--
lactamase fold:  
2yz3 β-lactamase VIM-2 from Pseudomonas aeruginosa  [133]; (E-value 1.3E-32) 
2fhx  β-lactamase SPM-1 from Pseudomonas aeruginosa [134]; (E-value 2.3E-30) 
2vw8 Quinolone protein from Pseudomonas aeruginosa PAO1 [135]; (E-value 2.7E-30) 
3q6x  β-lactamase NDM-1 from Klebsiella pneumoniae [136]; (E-value 7E-31) 
2cfu   SdsA1-hydrolase from Pseudomonas aeruginosa [83]; (E-value 7E-30)  
2q9u  A-type flavoprotein from Giardia  intestinalis [137]; (E-value 1E-26) 
1xm8 Glyoxalase II from Arabidopsis thaliana [138]; (E-value 1.1E-26)   
1e5d Rubredoxin from Desulfovibrio gigas [139]; (E-value 3.9E-26) 
 
A BLAST search (Basic Local Alignment Search Tool [140]) found several highly similar protein 
sequences in the non-redundant (NR) database. Thus, aMBL-1 was found to be similar to several Zn-
dependent hydrolases of the metallo-β-lactamase superfamily from Acinetobacter sp., and with proteins 
from other bacterial species:  
Accession Description 
Query 
coverage 
(%) 
E value 
Max 
ident 
(%) 
YP_001715574.1 Hypothetical protein ABAYE3862 [Acinetobacter baumannii AYE] 100 0.0 100 
YP_002317466.1 Metallo-β-lactamase family protein [Acinetobacter baumannii AB0057] 100 0.0 99 
YP_001085962.1 Putative signal peptide [Acinetobacter baumannii ATCC 17978] 100 0.0 99 
ZP_05830273.1 
Metallo-β-lactamase superfamily protein [Acinetobacter baumannii ATCC 
19606] 
100 0.0 99 
YP_001844693.1 Zn-dependent hydrolase [Acinetobacter baumannii ACICU] 100 0.0 99 
ADY82986.1 
Metallo-β-lactamase superfamily protein [Acinetobacter calcoaceticus 
PHEA-2] 
100 0.0 99 
YP_048103.1 
Conserved hypothetical protein; putative signal peptide [Acinetobacter 
sp. ADP1] 
96 6,00E-158 77 
NP_248747.1 Unnamed protein product [Pseudomonas aeruginosa PAO1] 86 2e-74 45 
ZP_05878299.1 Metallo-β-lactamase family protein [Vibrio furnissii CIP 102972] 96 1,00E-75 41 
To define ordered regions that are usually more prone to crystallization, secondary structure 
elements were predicted by PSIPRED [141] and disordered regions by GlobPlot [142]. aMBL-1 was defined 
as a globular protein with a predicted signal sequence at the N-terminal region. Analysis of the protein 
sequence with LipoP server [143] suggested a signal peptide with a cleavage site between Ala25 and 
Gln26.  
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Figure 12: Analysis of the aMBL-1 amino acids sequence. (A) Analysis of the presence of a signal peptide in the protein sequence of 
aMBL-1 (M1-A25) using the LipoP server. (B) Secondary structure prediction of aMBL-1 by the PSIPRED server (pink cylinders 
represent α-helix structure (H), yellow arrows are β-sheets (E) and the black line shows the coil region (C)). 
 
Crystallization propensity predictions based on the peptide sequence were performed with 
XtalPred [144]. According to statistical analysis and additional protein sequence properties (sequence 
length, isoelectric point, percentage of coil structure…), this protein showed a higher tendency to 
crystallize once the predicted signal peptide was removed.  
In conclusion, aMBL-1 is a globular protein with a predicted αβ/βα fold of the metallo-β-
lactamase superfamily. It is highly conserved among different strains of the Acinetobacter sp., and it is also 
conserved in other bacterial species. 
 
2. Cloning 
The gene encoding aMBL-1 was amplified by PCR from the genome of Acinetobacter baumannii 
strain AYE using the primers designed on the basis of the nucleotide sequence (see Materials and 
Methods). One step PCR subcloning technique allowed the insertion of the aMBL-1 coding sequence into 
the bacterial plasmid expression vector pGEX-6p-2 between the BamHI and EcoRI restriction sites. This 
vector expresses the coding sequence for aMBL-1 (amino acids from Gln26 to Pro288) with an N-terminal 
GST fusion-tag and a 3C-protease cleavage site between them. This cloning strategy leaves five extra 
residues at the N-terminus of aMBL-1 after removing the GST-tag (GPLGS). The fused protein (GST-aMBL-1 
[26-288]) has a calculated molecular weight (MW) of  56 KDa. 
 
3. Protein expression and purification 
3.1. PROTEIN EXPRESSION 
E. coli strain Rosetta (DE3) pLysS was used for small- and large-scale expression of aMBL-1. The 
experiment was carried out as described in Materials and Methods. In order to check the expression level 
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and the soluble fraction of the protein, after cell lysis and centrifugation, pellet and supernatant samples 
were loaded on 15% SDS polyacrylamide gels (Figure 13). The supernatants showed an overexpressed 
band with approximate, the same MW as the GST-aMBL-1 fusion protein. 
 
3.2. PROTEIN PURIFICATION  
aMBL-1 was purified following the protocol described in Materials and Methods. Briefly, after 
sonication and centrifugation, the soluble fraction was loaded onto a GST-HiTrap column followed by on-
column cleavage of GST tag with 3C-protease, overnight at 4 °C with a yield of approximately 95%. Then, 
the target protein ( 30 KDa) was eluted with the cleavage buffer. The GST-tag, that remained bound to the 
column, was extracted from the column with the elution buffer. 
Further purification of the sample was carried out through a size exclusion chromatography step 
(Sephacryl S-100). The second elution peak (lanes 11 to 13) of the chromatogram showed a very pure 
protein as could be seen by SDS PAGE (Figure 13). These fractions were treated separately and used for 
the crystallization experiments. 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Purification of aMBL-1. Sephacryl S-100 column elution profile of the protein eluted in the second peak as confirmed by 
SDS PAGE.  The inset shows the analysis by SDS-PAGE of the different purification steps of the protein (M, molecular weight 
markers; 0h: sample before induction; 4h, sample after 4h induction with IPTG, S, supernatant; C, eluted protein after cleaving 
with 3C-protease; E, elution of the GST-Tag with 10 mM reduced glutathione; 8-14, corresponding fractions of the size-exclusion 
chromatography. 
 
3.3. PROTEIN IDENTIFICATION BY MALDI-TOF-MS 
A mass fingerprint of aMBL-1 was obtained by MALDI-TOF mass spectrometry. The protein band 
was excised from the gel followed by limited proteolytic digestion using trypsin. The peptide masses of the 
breakdown products were compared to that of the theoretically tryptic peptides, and fourteen tryptic 
peptides were identified. They cover 67 % of the protein sequence and showed different percent 
confidence intervals: 99.0 (green), 97.4 (purple) and 18.4 (red). 
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3.4. EXPRESSION OF SeMET-LABELED PROTEIN 
The expression and purification of the SeMet-labeled aMBL-1 were the same as those used for 
the native protein. SeMet incorporation was confirmed by mass spectrometry [145]. Sequence analysis 
and mass spectrometry experiments were consistent with substitution of the five methionine residues 
(expected mass increase of 234 Da) (Figure 14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Mass spectra of the native (brown) and the SeMet 
labeled (green) aMBL-1. 
 
 
4. Biophysical  characterization 
Structural studies require conditions where the protein has not only a high degree of purity but 
also it is stable and structurally homogeneous. Through gel filtration, an estimation of the molecular 
weight of aMBL-1 could be performed comparing its retention volume (Vr) with the values obtained for 
several known calibration standards eluted from the same column under similar conditions.  
Moreover, analytical ultracentrifugation (AU) experiments provide valuable details about 
dynamic interactions, solution conformation and oligomerization properties of protein molecules by 
exposing them to large centrifugal forces [146]. 
 
4.1. ANALYTICAL GEL FILTRATION  
The elution profile of aMBL-1 shows one single peak eluting at 14.94 ml (Figure 15). This 
corresponds to an apparent molecular mass of 54.95 ± 5 KDa. This indicates that this protein is present as 
a dimer in solution. 
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Figure 15: Elution profile of aMBL-1 (black line). Broken lines represent the different molecular weight standards used for 
calibrating the column. 1, Catalase (240 KDa), 2, Bovine Serum Albumin (68 KDa), 3, Cytochrome C (13 KDa). And 1, Ferritin (450 
KDa), 2, Aldolase (158 KDa), 3, Egg albumin (45 KDa), 4, Chymotrypsinogen A (25 KDa).  
 
4.2. ANALYTICAL ULTRACENTRIFUGATION  
The oligomerization state in solution of aMBL-1 was analyzed by analytical ultracentrifugation 
(AU) [104]. The sedimentation profile of the protein obtained in the velocity experiments (Figure 16) 
showed a single peak with a sedimentation coefficient of 3.7 ± 0.1 S for all tested protein concentrations 
(see Materials and Methods).This corresponds to an estimated molecular weight of 55,124 Da. 
A more precise determination of the molecular mass of the single species of aMBL-1 present in 
solution, as seen by sedimentation velocity was carried out by sedimentation equilibrium. The 
experimental data could be fitted to the presence of a monodisperse single species in solution with an 
apparent molecular mass of 59,400±550 Da. This corresponds to the presence of a dimer in solution 
(Figure 16). 
 
 
 
 
 
 
 
 
 
Figure 16: Analytical ultracentrifugation experiments of aMBL-1. (A) 
Sedimentation velocity profile. (B) Sedimentation equilibrium experiment 
(the orange line in the upper panel represents the sedimentation 
equilibrium profile of a dimer of aMBL-1). 
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5. Protein crystallization 
Initial crystallization assays were carried out by the sitting drop vapour-diffusion method using 
sparse matrix crystallization screens at 22 °C [134]. The protein used for crystallization was in 50 mM Tris-
HCl, buffered at pH 7.5, containing 100 mM NaCl and 1 mM DTT at 20 mg/ml with drops of 0.2 + 0.2 µl 
(protein + reservoir solution). Initial crystal hits from the commercial crystallization kits are shown in 
Figure 17.     
 
Figure 17: Initial crystal hits of aMBL-1 from the commercial crystallization kits: (a) CUSTOM I - (A12): 27.49 % PEG-MME 5K, 100 
mM Imidazole-Maleate 7.5; (b) CUSTOM I - (E10): 35.09 % PEG 2K, 1.12 % Ethanol, 0.67 % LDAO; (c) Jena Bioscience Classics 2 - 
(C3): 25 % W/V PEG 4000, 100 mM MES Sodium Salt 6.5, 200 mM Magnesium Chloride; (d) Jena Bioscience Classics 7 - (C5): 30 % 
MPD, 10 % w/v PEG 4000, 100 mM Imidazole-HCl 8.0; (e) CUSTOM IV – (D9): 26.43 % PEG 6K, 100 mM BisTriPro 4.5; 
 
These initial crystallization conditions were further optimized to improve diffraction quality. 
Refinement of conditions A12 from CUSTOM I, C3 from Jena Bioscience Classics 2, C5 from Jena Bioscience 
Classics 7 and D9 from CUSTOM IV were carried out varying the precipitant concentration and the buffer 
pH in a fine gradient, while keeping fixed the other components of the solution. For condition E10 from 
CUSTOM I, the concentration of the detergent (LDAO) was kept constant varying the concentration of 
PEG2K and the percentage of ethanol. 
The best diffracting crystals grew in the optimized CUSTOM I (E10) solutions (45-49 % PEG2K, 1.2-
1.7 % ethanol and 0.67 % LDAO) in 1-2 weeks using a drop size of 0.5 l (Figure 18).  The typical crystal size 
was 400 x 60 x 60 µm. The initial trials with the commercial solution gave crystals that belonged to the P21 
monoclinic space group. However, the home made solutions of this condition gave crystals that belonged 
to the P212121 orthorhombic space group.  
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Orthorhombic crystals obtained using the home made E10 condition from CUSTOM I. (a) 45 % PEG2K, 1.2 % Ethanol, 
0.67 % LDAO; (b) 47 % PEG2K, 1.5 % Ethanol, 0.67 % LDAO; (c)  47 % PEG2K, 1.7 % Ethanol, 0.67 % LDAO; (d) 49 % PEG2K, 1.5 % 
Ethanol, 0.67 % LDAO. 
 
 
 
 
 
 
(a) (b) (c) (d) 
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6. Structure determination 
6.1. NATIVE DATASETS 
6.1.1. DATA COLLECTION AND PROCESSING 
aMBL-1 crystallized in two different space groups (Monoclinic and Orthorhombic). Two high-
resolution datasets were collected on ID14-1 and ID14-4 beamlines at the ESRF (Grenoble, France) at 
cryogenic temperatures. Crystals were cryoprotected with 5-15% PEG 400 in the crystallization condition 
and then flash-cooled in liquid nitrogen. 
The monoclinic crystal form diffracted X-rays to significantly higher resolution (1.7 Å) than the 
orthorhombic crystal form (1.9 Å) (Figure 19). This lower resolution could be explained because 
monoclinic crystals were collected at ID14.4, a beam line which is about 10 times more intense than 
ID14.1, but also by the solvent content. It should be mentioned that orthorhombic crystals contained 
higher solvent content than the monoclinic one (44.0 and 38.6 %, respectively).   
 
 
 
Figure 19: Diffraction pattern of the native orthorhombic crystal form of aMBL-1. 
 
 
Data were integrated with MOSFLM [111]. The unit cell dimensions, crystal symmetry and crystal 
orientation were obtained from the experimental diffraction pattern. Then, a local scaling of the data was 
applied to reduce systematic errors with programs of the CCP4 suite (see Materials and Methods). Data 
collection statistics are summarized in Table 7. 
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Table 7: Data collection statistics for aMBL-1 crystals 
 Monoclinic Orthorhombic 
X-ray source ESRF/ID14.4 ESRF/ID14.1 
X-ray detector Q315r ADSC CCD Q210 ADSC CCD 
Wavelength (Å) 0.97700 0.93340 
Space group P 21 P 21 21 21 
a,b,c (Å) 52.71, 56.18, 79.98 44.35, 86.41, 135.15 
α,β,γ (°) 90.00, 93.59, 90.00 90.00, 90.00, 90.00 
Matthews coefficient (Å 
3 
Da
-1
) 2.00 2.19 
Solvent content (%) 38.64 44.00 
Molecules in the asymmetric 
unit 
2 2 
Resolution range (Å)* 79.83 – 1.70 (1.79 – 1.70) 45.05 – 1.90 (2.0 – 1.90) 
Number of observations* 171137 (17384) 296679 (41900) 
Unique reflections* 50385 (6658) 41051 (6030) 
Completeness (%)* 97.9 (89.7) 99.9 (99.7) 
Multiplicity * 3.4 (2.6) 7.1 (6.8) 
R sym 
a
* 0.061 (0.294) 0.051 (0.493) 
R meas
b
* 0.072 (0.368) 0.055 (0.533) 
R pim 
c
* 0.038 (0.217) 0.021 (0.202) 
Mean I/σ(I)
d
* 13.9 (3.6) 26.7 (3.8) 
 
 
a
  Rsym = Σhkl Σi |Ii(hkl) - <I(hkl)>| / Σhkl Σi Ii(hkl); 
b
 Rmeas = {Σhkl [N/(N-1)]1/2 Σi |Ii(hkl) - <I(hkl)>|}o / Σhkl Σi Ii(hkl), where Ii(hkl) 
are the observed intensities, <I(hkl)> are the average intensities and N is the multiplicity of reflection hkl; 
c
 Rp.i.m. = Σ √(1/n-1) | 
IhI - <Ih>| / Σ | <Ih>|; 
d
 [I/σ(I)] is the relation between the intensity of the diffraction and the background; *Values in parentheses 
are for the highest resolution shell. 
 
An initial molecular replacement search was carried out separately for both crystal forms with 
Molrep [147] from the CCP4 package. No reasonable solutions could be retrieved using the coordinates of 
several members of the MBL superfamily (2fhx with 36% of identity, 2yz3 with 35% of identity) as search 
models.  
 Due to the failure of the molecular replacement, crystals of the SeMet labeled aMBL-1 were 
obtained in order to obtain the phases through experimental methods (Multiple-wavelength Anomalous 
Dispersion).  
 
6.2. DERIVATIVE DATASETS 
6.2.1. DATA COLLECTION AND PROCESSING 
The Se-Met labeled aMBL-1 protein produced crystals that belonged to the orthorhombic space 
group P212121. The presence of selenium atoms was confirmed by X-ray fluorescence (Figure 20) and three 
datasets at three different wavelengths were collected at ID14.4 beamline (ESRF-Grenoble, France). The 
fluorescence scan was used to determine the peak, inflection and remote experimental wavelengths for 
the Se present in the protein. 
Energy (eV) f´ f´´ 
12.6597 -8.51 5.70 
12.6577 -9.66 3.36 
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Figure 20: Experimental anomalous scattering curves from a crystal of Se-Met labeled aMBL-1. The f’’ (blue curve) is proportional 
to the atomic absorption coefficient at the K absorption edge of Se. Dispersive difference between data is proportional to the 
difference in f’ (red curve).  
 
The three datasets collected at the peak, inflection and remote wavelengths of the selenium 
were indexed, integrated and reduced using XDS and scaled with SCALA from the CCP4 suite. Local scaling 
of the data was applied to reduce errors among the datasets and to place the data on an approximately 
absolute scale. Data collection statistics of SeMet labeled aMBL-1 crystals are summarized in Table 8. 
 
Table 8: Data collection statistics for SeMet labeled aMBL-1 crystals 
 PEAK INFLECTION REMOTE 
X-ray source ESRF/ID14.4 
X-ray detector Q315r ADSC CCD 
Oscillation range (°) 1.0 
Exposure Time (s) 0.4 
Wavelength (Å) 0.9794 0.9795 0.9770 
Space group P212121 
a,b,c (Å) 45.95, 87.61, 137.27 45.78, 87.52, 136.98 45.80, 87.72, 137.12 
α,β,γ (°) 90.00, 90.00, 90.00 
Matthews coefficient  
(Å 
3 
Da
-1
) 
2.34 
Solvent content (%) 47.57 
Molecules in the 
asymmetric unit 
2 
Resolution range (Å) 45.79 - 2.40 (2.53 - 2.40) 45.78 - 2.65 (2.79 - 2.65) 45.78 - 2.85 (3.0 - 2.85) 
Number of observations* 176916 (25865) 118017 (17320) 105406 (15488) 
Unique reflections* 22393 (3210) 16659 (2382) 13502 (1925) 
Completeness (%)* 99.8 (100.0) 99.7 (100.0) 99.7 (100.0) 
Anomalous 
completeness 
99.9 (100.0) 99.8 (100.0) 99.8 (100.0) 
Anomalous multiplicity 4.2 (4.2) 3.8 (3.8) 4.2 (4.2) 
R meas 
a
* 0.088 (0.551) 0.073 (0.527) 0.090 (0.444) 
R pim 
b
* 0.041 (0.263) 0.037 (0.268) 0.048 (0.242) 
Mean I/σ(I) 
c
* 15.4 (3.2) 20.2 (4.1) 17.8 (3.4) 
Anomalous signal⁺ 1.027 0.837 0.864 
Phasing power⁺ 1.162 - - 
Figure of merit⁺ 0.45 - - 
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a
  R meas = {Σhkl [N/(N-1)]1/2 Σi |Ii(hkl) - <I(hkl)>|} / Σhkl Σi Ii(hkl), where Ii(hkl) are the observed intensities, <I(hkl)> are the 
average intensities and N is the multiplicity of reflection hkl; 
b
 R p.i.m. = Σ √(1/n-1) | IhI - <Ih>| / Σ | <Ih>|; 
c
 [I/σ(I)] is the relation 
between the intensity of the diffraction and the background; *Values in parentheses are for the highest resolution shell. ⁺ Values 
at 3.0 Å resolution. 
 
 
6.2.2. STRUCTURE DETERMINATION AND REFINEMENT 
Probably due to the low phasing power, the Patterson maps didn’t show clear peaks at the 
corresponding Harker sections. Heavy-atom sites, initial phases, map calculation and density modification 
were carried out with the program AutoSHARP [120] at 2.39 Å , using the peak, inflection and remote 
datasets, with the peak as the reference. The 10 expected Selenium sites were found (Table 9) and used 
for the estimation of the initial phases.  
 
Table 9: Final coordinates and occupancies of the Se atoms 
 (fractional coordinates)     
Se atom x  y z Occupancy 
1 0.2213    0.2105    0.1854 0.2774 
2 0.4652 0.3063 0.1841 0.3442 
3 0.8275    0.4649   0.0681 0.2774 
4 0.2640 0.4402  0.2688 0.3046 
5 0.6274   0.5982   0.1359 0.2506 
6 0.3073   0.1227    0.2041 0.2860 
7 0.0468   0.2372    0.3043 0.2844 
8 0.6523   0.4573    -0.0595 0.2519 
9 0.5617  0.5137    0.1053 0.2180 
10 0.3816 0.6223    0.0091 0.1976 
 
The MAD maps were calculated on both hands. Two criteria were used to choose the correct 
hand: 1) the correlation coefficient between observed E2 values (normalized structure factors [148]) and 
E2 values based on the modified map and 2) by inspection of the resulting electron density maps. The 
initial map (Figure 21a) shows clear boundaries between the protein and the solvent. Phases were further 
improved by density modification and a closer inspection revealed some secondary structure elements, 
such as the two -helices in Figure 21b showing clear density for the side chains. 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: Resulting electron density map where (a) clear boundaries between protein and solvent region can be identified. (b) 
Clear electron density map of two parallel helices and the lateral chains of some aromatic residues. 
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An initial model of the content of the asymmetric unit was obtained with the program 
AUTOBUILD implemented in the PHENIX suite [121] using the initial phases (in form of Hendrickson-
Lattman coefficients) obtained with the program SHARP. 
The initial model was built automatically, and consisted of 519 residues in 22 fragments and 76 
waters ([R/Rfree]=0.2923/0.3514 values and CC=75 %). A final model was obtained after several rounds of 
iterative manual building Coot [122] and refinement PHENIX using the 2.4 Å peak dataset with Rwork and 
Rfree values of 21.6 and 25.5%, respectively. Finally, this model was further refined against the native 
orthorhombic data set up to a resolution of 1.9 Å 
The final model was optimized in an iterative process of refinement and manual model building, 
applying translation-libration-screw (TLS) groups which were identified by PHENIX, using a method similar 
to that defined by the TLSMD server [149]. Then, molecules were analyzed for inter-domain motions or 
flexibility and individual chains were partitioned into multiple segments that were modeled as rigid 
bodies.  
After the structure for the orthorhombic crystal form of aMBL-1 was solved, the monoclinic 
crystal structure was elucidated by molecular replacement using the orthorhombic model and then 
refined up to a resolution of 1.7 Å. This allowed a better fit of some regions of the molecule that were not 
well defined in the electron density maps from the orthorhombic crystals.  
Finally, water molecules were added automatically with Coot and checked manually at the final 
refinement step for both crystal forms. The final refinement statistics are shown in Table 10. 
  
Table 10: Refinement analysis of aMBL-1  
Space group P21 P212121 
Resolution (Å) 1.7 1.9 
No. of reflections 50368 41826 
R 
a
 (Rfree 
b
) (%) 15.44 (18.48) 17.07 (21.86) 
Number of atoms   
Protein 4756  4514 
Water 602 378 
Cl - 3 
SO4 - 1 
PEG - 1 
BEZ 2 2 
R.m.s.d. 
c
    
Bond length (Å) 0.007 0.006 
Bond angles (
o
) 1.058 1.019 
B factor 
d
 (Å
2
)   
Protein (main/side chain) 13.74/20.36 27.81/33.70 
solvent 25.44 34.95 
 
a
 R = hkl {[Fobs(hkl)] - [Fcalc(hkl)]} / hkl [Fobs(hkl)], where Fobs(hkl) and Fcalc(hkl) are the observed and calculated structure 
factors, respectively. 
b 
Rfree corresponds to R calculated using 5 % of the total reflections selected randomly and excluded during 
refinement; 
c
 R.m.s.d. is the root mean square deviation. 
d
 B-factor indicates the true static or dynamic mobility of an atom. 
 
6.3. VALIDATION OF THE STRUCTURE 
The aMBL-1 structure displayed two chains in the asymmetric unit together with 807 water 
molecules and two ligands (benzoate, BEZ). Five residues, Asn184, Glu188 and Arg247 in subunit A and 
Tyr67 in both subunits, have been modeled in dual conformations. As the monoclinic crystal form diffracts 
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to higher resolution than the orthorhombic one, the P21 structure will be used as the representative 
model in all further discussions.  
The final model has a good geometry with 97 % of the residues located in the most favored 
regions of the Ramachandran plot and only one residue was located in the outlier region, adopting an 
unusual backbone conformation: Asn57 in both subunits, although it is perfectly fitted in the electron 
density map (Figure 22a). Summary statistics from the protein geometry obtained for the final model are 
summarized in Figure 22b. 
 
Figure 22: (a) 2Fo-Fc electron density map in the region of Asn57 contoured at 1.2σ. (b) The quality of the final refined model of 
aMBL-1 was overall very good, with [R/Rfree]=0.1544/0.1848 values and displaying a good stereochemistry as defined by 
Molprobity.   
 
 
7. Architecture of aMBL-1 
7.1. OVERALL FOLDING 
The monomer of aMBL-1 has a globular shape with approximate dimensions of 55 x 42 x 42 Å. 
The secondary structure elements are organized in a typical αβ/βα fold that characterizes the MBL 
superfamily (Figure 3a) [35] [61]. The central core composed by the two -sheets of six (A1-A6) and five 
strands (B1-B5), facing each other, is surrounded by five solvent exposed α-helices. The first β-sheet (A) is 
formed by β-strands A1 (from residue Lys29 to Leu34), A2 (Thr43-Glu48), A3 (Glu52-Leu55), A4 (Thr78-
Phe83), A5 (Gln106-Ala109) and A6 (Gln144-Ala146), while the second includes β-strands B1 (Thr150-
Leu153), B2 (Glu156-Lys163), B3 (Leu166-Val171), B4 (Ala176-Val178) and B5 (Lys216-Val219). Both β-
sheets have mixed parallel (A3, A4, A5 and A6; B4 and B5) and antiparallel (A1, A2 and A3; B1, B2, B3 and 
B4) β-strands. They are linked on one side by 3-helix and a 10 residue-long loop (Gly133-Pro143), 
whereas on the other side strands A2 and B5 are connected by hydrogen bond interactions (Gly41-Met223 
and Thr43-Ala221) as well as by a tight packing of hydrophobic residues. The connectivity of the structural 
elements is shown in Figure 23b.  
Four of the -helices (1 (Lys62-Ser75), 2 (Leu95-Tyr101), 4 (Thr197-Ala212) and 5 (Gly230-
Ala250) are flanking both sides of the plane of the -sandwich, two (1 and 2) on the side of sheet A and 
two (4 and 5) on the side of sheet B whereas helix 3 (Pro111-Met132) covers one face of sheet A 
(Figure 23a).  
This protein also presents two extra helices 6 (Ala254-Gln264) and 7 (Val271-Val281) (Figure 
23, purple) located at the C-terminal region. These helices, not belonging to the MBL fold, are placed 
covering the entrance to the putative active site of a typical protein with this type of fold. 
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(a)  
(b)  
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Figure 23: Structure of aMBL-1. (a) Ribbon diagram of the aMBL-1 monomer. The benzoate molecule is represented in ball-and-
stick mode. (b) Topological diagram of the structure of aMBL-1. Secondary structure elements are labelled according to their 
position in the primary sequence, also the N and C termini are labelled as N and C, respectively. α-helices are shown as red and 
purple cylinders and β-strands as yellow arrows. 
 
There is a molecule, interpreted as benzoate, at the mouth of the putative active site (Figure 
23a), blocking its entrance. 
There are two -bulges in the structure of aMBL-1. The first one located at the -strand A4 is a 
classic bulge formed by 3 residues: Leu79, Lys80 and Val53. The second -bulge is a G1 bulge placed at the 
-strand B4, in which the first residue is in the alpha left conformation: Val171, Lys175 and Ala176 (Figure 
24). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24: Ramachandran plots for the β-bulges, showing the ψ/φ angles of the residues involved. The red circle corresponds to 
the ψ/φ angles of residue X, and the green and blue squares correspond to residues 1 and 2, respectively. The type of bulge is 
indicated above the Ramachandran plot. To the right of the Ramachandran plot is a schematic diagram indicating the residues and 
hydrogen bonding patterns in and around the beta bulge. 
 
 
7.2. DIMER INTERFACE 
The asymmetric unit of both crystal forms of aMBL-1 are composed by two monomers related by 
a non-crystallographic 2-fold axis, similar to other proteins that present the MBL fold [78] [83] [74].  
The solvent accessible surface area of both monomers is 11,700 Å2 with an interface area of 630 
Å2 that falls within the range of values reported for dimeric proteins [150]. These data might indicate that 
the protein is a dimer in solution (Figure 25a). 
The major part of the dimer interface is formed by helix 1 of each monomer that pack against 
each other in a head-to-tail fashion (Figure 25). Although the nature of the dimer interface is 
predominantly hydrophobic, polar interactions between the subunits involving hydrogen bonds and Arg-
Asp salt bridges are also observed. The interface may be subdivided into three zones according to the 
main interactions (Figure 25b).  
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Figure 25: Dimer interface of aMBL-1. (a) View of overall conformation of the dimer and the interaction interface indicated by the 
black square. (b) Close-up view of the interactions between monomers at the dimer interface with representation of the side 
chains of residues (sticks) involved in the dimerization. The dimer interface has been divided into three zones, according to 
location and type of interactions. For clarity, only residues of zone II on the close side of the helix are represented, those on the 
far side, that are a copy of those represented, are not shown. H-bonds are represented by the black dashed lines. 
 
Zone I is made up by residues from helix α1 of both monomers and defined the central nucleus of 
the dimer interface. Leu66 and Leu73 from one monomer establish hydrophobic interactions with the 
corresponding symmetry related residues from the neighboring monomer (Figure 25b).  
Zone II is located above this central nucleus and made up, mainly by salt bridges fixing the side 
chains of the residues involved. They are located at the edge of helix α1 (Arg67) in each monomer 
reinforced by the side chains of Asn71 and Asp74 from neighboring monomers. Additional residues, Lys36 
and His39, from the same monomer close to Arg67, help to stabilize the dimer interface (Figure 25b).  
Zone III is made up by residues belonging to helix α2 (Gln100, Tyr101) from both monomers. A 
symmetrical network of hydrogen bond interactions involving the corresponding side chains help to 
stabilize this region and further enhanced by hydrophobic interactions between Leu73 and the aromatic 
ring of Tyr101 (Figure 25b). 
A summary of the interactions occurring at the dimer interface is shown in Table 11. 
 
Table 11: Contacts between monomers at the dimer interface 
Monomer A Monomer B Distance (Å) Comments 
Zone I  
CB L66  O L66 3.97 Hydrophobic interaction 
CD1 L66 CD1 L73 3.69 Hydrophobic interaction 
CD2 L66  CD2 L66 3.86 Hydrophobic interaction 
Zone II  
NH1 R67 OD2 D74 2.90 Salt bridge 
NH2 R67 OD1 N71  2.93 Salt bridge 
NH2 R67 OD2 D74  2.87 Salt bridge 
OD1 N71 NH2 R67  2.86 Salt bridge 
OD2 D74 NH1 R67  2.94 Salt bridge 
OD2 D74 NH2 R67  2.80 Salt bridge 
Zone III  
OE1 Q100 NE2 Q100 2.83 Hydrogen bond 
NE2 Q100 OE1 Q100 2.76 Hydrogen bond 
OH T101 OH T101 2.71 Hydrogen bond 
 
 
7.3 PUTATIVE ACTIVE SITE 
Most members of the MBL superfamily present a conserved sequence motif, His-X-His-X-Asp/His, 
that binds the metal atoms and forms the active site of these proteins (Figure 26B) [63]. 
Sequence and structure alignment of aMBL-1 with other members of the superfamily did not 
show this conserved motif. The corresponding sequence motif in aMBL-1 is made up by the residues Tyr-
X-Asp-X-Asp/His (Figure 26B). Only the last two residues are conserved; but the first two His residues of 
the motif that bind one of the metal atoms of the active site are not conserved (Figure 26A and B). These 
two residues have been substituted by residues that will not be able to bind any metal atom the same way 
as the typical motif of this superfamily. Also, the third His residue involved in the binding of one of the 
metal atoms (His 189, Figure 26B) is not present in aMBL-1, and has been substituted by an Ile181 (Figure 
26B). 
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Figure 26: (A) Putative active site of aMBL-1. Residues equivalent to the conserved metal binding motif of the MBL superfamily are 
represented as sticks. Red balls represent two solvent molecules. (B) Structural alignment of the putative active site of aMBL-1 
(blue) with the metal binding motif of the New Delhi-metallo-β-lactamase (NDM, green). Green balls represent solvent molecules 
from aMBL-1; and blue balls, labeled as Zn, represent the two zinc ions in the active site of NDM. 
 
 
Although the geometry of the active site is superficially reminiscent of that observed in other 
members of the MBL superfamily [35], no Zn atoms could be placed in the density observed in this 
putative active site. The density found at the active site, in the place where one Zn atom is located on the 
typical metal binding motif, accounts for one molecule of water (Wat1, Figure 26A). This molecule is 
surrounded by Tyr86, Asp88, Asp90, His222 and Ile181, and displays a tetrahedral coordination through 
one interaction with Asp88 (2.7 Å), another with His222 (3.3 Å), two more with Asp90 (2.8 and 3.3 Å), and 
the last interaction, that completes the coordination sphere is to another solvent molecule (Wat2, Figure 
26A). 
 The putative active site of aMBL-1 is located in a deep cavity, and made up by the loops that 
connect the secondary structure elements A1-A2, A2-α2 and B3-α5 (Figure 27A). The two C-terminal 
helices (α6 and α7) are located at the entrance of the putative active site blocking the access to the bulk 
solvent (Figure 27A).  
 
At the entrance of the putative active site there is a hydrophobic cavity made up by three 
aromatic residues (Phe40, Trp128 and Trp287), Pro89 and Lys124 (Figure 27B). In this cavity there is an 
extra electron density. This density has been interpreted as a molecule of benzoate due to the shape of 
the electron density and the nature of the interactions (Figure 27B).  
Figure 27: Putative active site of aMBL-1. (A) Location of the active site in the structure. (B) Electron density |2Fo|-|Fc|, contoured 
at 2σ, modelled as benzoate (BEZ). Hydrogen bonds are indicated by black dashed lines. 
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The aromatic ring of the benzoate establishes two parallel displaced - stacking interactions, 
one with the aromatic ring from Phe40 and other with Pro89. The two oxygens of the benzoate forms 
hydrogen bond interactions with the ring nitrogens of Trp287 (3.24 Å) and Trp128 (2.67 Å), and a third 
interaction to the -amino group of Lys124 (2.7 Å) (Figure 28). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28: LIGPLOT representation of the hydrogen-bond network involving the benzoate in the putative active site of aMBL-1. 
Hydrogen bonds are indicated by green dashed lines, while hydrophobic contacts are represented by an arc with spokes radiating 
towards the ligand atoms they contact. 
 
7.4. CRYSTAL PACKING IN THE TWO CRYSTAL FORMS 
The structure of aMBL-1 was solved in two different crystal forms: monoclinic (P21) and 
orthorhombic (P212121). The structure was first solved to 2.4 Ǻ using the orthorhombic crystal form and a 
three-wavelength SeMet MAD experiment, and the monoclinic crystal form was solved by molecular 
replacement to 1.7 A using the coordinates of the orthorhombic crystals. In both structures, the 
asymmetric unit contains two molecules arranged in a head-to-tail manner with subtle differences in the 
interactions between the subunits.  In the monoclinic form, the dimer interface is formed by contacts 
between the long loop region that connects helix α3 to the β-strand A6 (residues Gly133-Pro143) (Figure 
29a). In the orthorhombic crystal form, the subunits are arranged in such a way that monomers A contact 
via helix α2 and helix α5 and through helix α4 from chain A with helix α2 from chain B. 
Figure 29: Arrangement of the aMBL-1 dimers in the two crystal forms: (A) Monoclinic (P21) and (B) orthorhombic (P212121). The 
homodimers are depicted in purple (Chain A) and in cyan (chain B) and the interactions area is highlighted in pink. 
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Superposition of the homodimers in both crystal forms showed the same dimerization interface 
but with small differences at the C-terminal. The rms deviation value was 1.567 Å for all C atoms.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30: (Right) Superposition of the C traces of the dimeric aMBL-1 observed in the two different crystal forms by Superpose 
program from CCP4. (Left) Superposition of the Cα traces of monomers obtained from the two different crystal forms. The main 
difference between P21 (red) and P212121 (blue) crystal structures was observed at the C-terminus of the protein. 
 
7.5. FUNCTIONAL ASSAYS 
7.5.1. SUSCEPTIBILITY TESTING 
After confirmation of increased expression of aMBL-1 gene constructions in pE-TRA vector cloned 
into both strains (A. baylyi and A. baumannii ATCC 17978) by reverse-transcriptase PCR (RT–PCR) (29.09 
fold relative to the house-keeping gene, gyrB), different functional assays were carried out. The 
characterization goal was to find a biologically relevant function which confirmed the rest of conclusions 
got from initial x-ray crystallographic studies and to evaluate the hydrolytic efficacy against β-lactam 
antibiotics of the target protein. 
β-lactamase activity was tested by an adaptation of the Masuda method. It was found that 
background-lawn formation by E. coli DH5α cells incubated overnight was inhibited by β-lactam antibiotic 
confirming the non-hydrolytic activity of these enzymes toward β-lactam antibiotics. 
 
7.5.2. KINETIC EXPERIMENTS 
In order to determine which chemical reaction is catalyzed by aMBL-1, diverse enzymatic assays 
were performed using a set of general chromogenic substrates. These substrates were chosen in order to 
test all possible functions among members of the MBL superfamily with comparable overall structure. 
The β-lactamase activity was assayed against nitrocefin to confirm the previous negative results 
in the microbiological assays. The obtained results corroborate that aMBL-1 does not show any hydrolytic 
activity against β-lactam antibiotics.  
To determine the glioxalase type II function, experiments against S-D-lactoylglutathione were 
performed.  Any increament of absorbance at 412 nm was detected, confirming that aMBL-1 is also not 
active against this compound. 
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In order to analyze its phosphatase activity, serial dilutions of AMBL-1 samples were tested 
against the pNPP substrate. After 10-30 minutes of incubation at 37 °C any absorption change was 
observed at 405nm, confirming that the substrate has not been degraded. As indicative of 
phosphodiesterase activity, enzymatic assay against bispNPP were performed. In this assay, aMBL-1 did 
not display activity even when several phosphodiesters from the cell as single- and double-stranded DNA 
were tested. 
To test the esterase activity, p-nitrophenyl ester was used, determing the liberation of p-
nitrophenol by meassuring the absorbance at 410 nm.  No changes were observed certifying that aMBL-1 
did not hydrolyze this compound.  
Assays for detecting acyl-CoA thioesterase activity thioesterase were performed rendering also 
negative results.   
Finally, these assays were performed at different pH and supplying the buffer with different 
divalent metal ions (Mg2+, Mn2+…) showing the same negative results. 
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III. RESULTS 
CHAPTER 2:                                                                                                                                aMBL-2 
 
1. Sequence analysis 
1. 1. ALIGNMENT AND SEQUENCE ANALYSIS  
The ABAYE0164 gene encodes a protein, aMBL-2 (http://www.ncbi.nlm.nih.gov/gene/6000355) 
that was classified by the InterPro web server into the metallo-β-lactamase superfamily. In a BLAST search, 
AMBL-2 was found to be similar to several metallo-β-lactamases and Zn-dependent hydrolases.  
The prediction of the secondary structure elements performed with PSIPRED [141] is shown in 
Figure 31. In this protein no signal peptide sequence could be detected.  
 
 
  
Figure 31: Secondary structure prediction of aMBL-2 performed 
with the PSIPRED server. Pink cylinders represent α-helix 
structure (H), yellow arrows β-sheets (E) and the black line 
shows the coil region (C). 
 
 
 
 
 
 
 
 
Crystallization propensity predictions were performed with the XtalPred server [144] and aMBL-2 
showed a high tendency to crystallize. The HHpred server [132] found a collection of related proteins that 
share the typical β-sandwich fold of the MBL superfamily.  
 
2. Cloning  
The aMBL-2 gene was amplified by PCR from the genome of A. baumannii strain AYE using the 
primers designed on the basis of its nucleotide sequence (see Materials and Methods). Since BamHI 
restriction site was present into the aMBL-2 cDNA sequence, a silent mutation at the nucleotide position 
249 (see Materials and Methods) was performed to eliminate this site without affecting the translated 
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amino acid sequence of the protein. Clones containing the mutation were selected by restriction analysis 
(Figure 32), and its sequence was confirmed by DNA sequencing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32: Agarose gels. (a)(1) Amplification of the aMBL-2 gene. (b) Restriction analysis of the mutated aMBL-2 gene in the 
pCRBlunt vector: (2) linearized vector with a single BamHI site; (3) Non-digested vector. (c) Colony PCR for selection of positive 
clones (5, 6 and 8); (4) positive control (185 bp); (M) DNA molecular weight marker. 
 
The coding sequence for aMBL-2 was inserted into the bacterial plasmid expression vector pGEX-
6p-2 between the BamHI and EcoRI restriction sites. This vector expresses the coding sequence for aMBL-
2 (amino acids Met1 to Thr265) with an N-terminal GST fusion tag, and a 3C-protease cleavage site 
between them. 
 
3. Protein expression and purification  
3.1. PROTEIN EXPRESSION 
Overexpression of soluble aMBL-2 was carried out in E. coli Rosetta (DE3) pLysS strain at 37 °C in 
LB media, induced with a concentration of 1 mM of IPTG during 4 h (Figure 33). 
3.2. PROTEIN PURIFICATION 
The protein aMBL-2 was purified using the same protocol described for aMBL-1 (see Materials 
and Methods). 
 
 
Figure 33: Purification of aMBL-2. Sephacryl S-100 column elution profile. The protein eluted in the second peak as confirmed by 
SDS PAGE. The inset shows the analysis by SDS-PAGE of the different purification steps of the protein (M, molecular weight 
marker; 0h, sample before induction, 4h, sample after 4h of induction with IPTG; S, supernatant; W, eluted protein after cleaving 
with 3C-protease; E, elution of the GST-Tag with 10 mM reduced glutathione; 11-15, corresponding fractions of the size-exclusion 
chromatography. 
 
(a) (b) (c) 
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3.3. PROTEIN IDENTIFICATION BY MALDI-TOF-MS 
A mass fingerprint of aMBL-2 was obtained by MALDI-TOF mass spectrometry. The protein band 
was excised from the gel followed by limited proteolytic digestion using trypsin. The mass of the 
breakdown products were compared to that of the theoretically tryptic peptides, and fourteen tryptic 
peptides were identified. They cover 60.8 % of the protein sequence and showed different percent 
confidence intervals: 98.9 (green) and 18.4 (red). 
M G F E K T T S Q I L F D N G V H K C I S F T S L V K G E G I Q A N Q F L I I D H E R A A V I D P G G D L T Y V P L T M E L N K Y T R L K N L 
D Y V M A S H Q D P D I I T S M P R W L V Y T D A K V V A S K L W A R F L P H L N S S F M S E R M K G N W E D R L I E L P D R G Q V I Q 
L G E S K L V I I P A H F L H S V G N F Q F Y D P V A K I L F S G D M G A S I V D D A S Q P L K D F D S H V M K M K A F H Q R Y M C S N K 
V I R L W V N M I R Q M D I E M I V P Q H G S P F I G K E M I N Q F L D W I E T L P C G V D L M T E Q I F S C P T 
 
3.4. EXPRESSION OF SeMET-LABELED PROTEIN 
The expression and purification protocols for the SeMet labeled aMBL-2 were the same as those 
used for the native protein. SeMet incorporation was confirmed by mass spectrometry [145]. Sequence 
analysis and mass spectrometry experiments showed an increase of 703 Da in the labeled sample 
consistent with the substitution of fifteen methionine residues (Figure 34).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34: Mass spectra of the native (brown) and the 
SeMet labeled (green) aMBL-2. 
 
 
4. Biophysical characterization 
4.1. ANALYTICAL GEL FILTRATION  
The elution profile of aMBL-2 shows a single peak eluting at 14.88 ml (black line, Figure 35). This 
corresponds to an apparent molecular mass of 56.23±5 KDa. This indicates that this protein is present as a 
dimer in solution. 
Different standards are labeled as: 
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Figure 35: Elution profile of aMBL-2 (black line). Broken lines represent the different molecular weight standard used for 
calibrating the column. 1, Catalase (240 KDa), 2, Bovine Serum Albumin (BSA) (68 KDa), 3, Cytochrome C (13 KDa). And 1, Ferritin 
(450 KDa), 2, Aldolase (158 KDa), 3, Albumin egg (45 KDa), 4, Chymotrypsinogen A (25 KDa). 
 
 
 
4.2. ANALYTICAL ULTRACENTRIFUGATION  
The sedimentation profile of the protein obtained in the velocity experiment (Figure 36) shows a 
single peak with sedimentation coefficient of 4.2±0.1 S at the lowest protein concentration used (0.3 
mg/ml). This corresponds to an apparent molecular mass of 52,148 Da. At higher concentrations of 
protein (> 0.9 mg/ml) a second peak with a higher sedimentation coefficient appeared. 
Sedimentation equilibrium experiments carried out at the same concentrations could not be 
fitted to one single homogeneous species. Experimental data fitted well to a model containing more than 
one state (no uniform distribution of residuals) (Figure 36). 
The results of both experiments are consistent with the existence of dimer-tetramer equilibrium 
in solution. 
 
 
 
 
 
 
 
 
 
(A) 
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Figure 36: Analytical ultracentrifugation 
experiments of aMBL-2. (A) Sedimentation 
velocity profiles at the indicated protein 
concentrations. (B) Sedimentation 
equilibrium experiment of aMBL-2. The 
residuals (lower panel) show the non-
uniform fitting between the experimental 
data and an ideal single-species model (blue 
line). 
 
 
 
5. Protein crystallization  
Initial crystallization assays were carried out by the sitting drop vapor diffusion method using 
sparse matrix crystallization screens at 22 °C [151]. The protein used for crystallization was in 50 mM Tris-
HCl, buffered at pH 7.5, containing 100 mM NaCl and 1 mM DTT at 20 mg/ml with drops of 0.2 + 0.2 µl 
(protein + reservoir solution). Only one condition from the commercial crystallization kits produced 
crystals (B12 CUSTOM I, 19.43 % PEG-MME 2K, 10 mM EDTA and 0.68 % BOG). Further optimization of this 
condition (12 % PEG-MME 2K, 12 mM EDTA and 0.68 % BOG) gave quality diffracting crystals with an 
approximate final size of 400 x 100 x 100 µm (Figure 37). 
 
 
 
 
 
 
 
Figure 37: Crystals of aMBL-2 obtained with the optimized crystallization solution. 
 
 
 
 
mg/ml MW 
0.3 71.700±1000 
0.9 74.400±1000 
2.0 74.500±1000 
(B) 
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6. Structure determination 
6.1. NATIVE DATASETS 
6.1.1. DATA COLLECTION AND PROCESSING 
One native dataset was collected on ID14.4 beamline at the ESRF (Grenoble, France) at cryogenic 
temperatures. Crystals were cryoprotected with 15% PEG 400 in the crystallization condition. Crystals of 
aMBL-2 belong to the triclinic space group P1 and diffracted up to 2.2 Å. The unit cell contains four 
molecules per asymmetric unit as derived from self rotation function (Figure 38) and an estimation of the 
solvent content. Data collection statistics are summarized in Table 12. 
 
 
 
 
 
 
Figure 38: Self Rotation function at Chi 
= 180° and 90° calculated for the P1 
native data of aMBL-2. Two peaks at 
Chi = 180° and no peaks at Chi = 90° 
suggested the presence of a dimer of 
dimers. 
 
As for the first protein aMBL-1, no solution could be found using the molecular replacement 
method to solve the phase problem. Because of this SeMet labeled protein was produced, crystallized and 
X-ray diffraction data collected for this protein. 
 
6.2. DERIVATIVE DATASETS 
6.2.1. DATA COLLECTION AND PROCESSING 
Diffraction data of the aMBL-2 SeMet labeled crystals were collected at ID14.4 (ESRF, Grenoble, 
France). The experimental wavelengths for the peak, inflection and remote were chosen based on the X-
Ray fluorescence scan of the crystal (Figure 39). 
Energy (eV) f´ f´´ 
12.6597 -7.79 5.13 
12.6577 -9.30 3.23 
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Figure 39: Experimental anomalous scattering from a crystal of Se-Met labeled aMBL-2.  The f’’ (blue curve) is proportional to the 
atomic absorption coefficient for a given element at a given energy. Dispersive difference between data is proportional to the 
difference in f’ (red curve).  
 
A highly redundant peak dataset of the SeMet labeled crystal was collected (Figure 40). After 
collecting this dataset, most likely, the crystal suffered from radiation damage and no more data could be 
collected. Data collection statistics are summarized in Table 12. 
 
Figure 40: Diffraction pattern of the SeMet labeled triclinic crystal of aMBL-2. 
 
 
Table 12: Data collection statistics for aMBL-2 
 SeMet-peak NATIVE 
X-ray source  ESRF/ID14.4 
X-ray detector  Q315r ADSC CCD 
Resolution range (last shell) 
(Å)  
48.23 – 2.97 (3.13 – 2.97) 50.0 - 2.30 (2.42 – 2.30) 
Number of images  360 
Oscillation range (°)  1.0 
Exposure Time (s)  0.1 
Wavelength (Å)  0.9794 0.9393 
Space group  P1 
a, b, c (Å)  59.84, 64.82, 69.07 59.99, 64.56, 69.46 
α, β, γ (°)  81.92, 81.65, 75.87 82.10, 81.35, 75.88 
Matthews coefficient  
(Å3 Da
-1
)  
2.13 2.14 
Solvent content (%)  42.27 42.50 
Molecules in the asymmetric 
unit  
4 
Number of observations  151955 (18435) 159316 (23764) 
Unique reflections  19842 (2830) 40985 (6084) 
Completeness (%)  97.4 (94.6) 92.9 (94.8) 
Multiplicity  7.7 (6.5) 3.9 (3.9) 
Anomalous completeness  96.4 (93.0) - 
Anomalous multiplicity  3.8 (3.3) - 
R meas 
a
* 0.090 (0.522) 0.060 (0.465) 
R pim 
b
* 0.046 (0.282) 0.030 (0.234) 
Mean I/σ(I) 
c
* 17.6 (3.5) 15.19 (3.0) 
Anomalous signal⁺ 1.33 - 
Figure of merit⁺ 0.46 - 
Phasing power⁺ 2.07 - 
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a
 Rmeas = {Σhkl [N/(N-1)]1/2 Σi |Ii(hkl) - <I(hkl)>|}Patte / Σhkl Σi Ii(hkl), where Ii(hkl) are the observed intensities, <I(hkl)> are the 
average intensities and N is the multiplicity of reflection hkl; 
b
 Rpim = Σ √(1/n-1) | IhI - <Ih>| / Σ | <Ih>|; 
c
 [I/σ(I)] is the relation 
between the intensity of the diffraction and the background; *Values in parentheses are for the highest resolution shell. ⁺ Values 
at 3.0 Å resolution. 
 
 
6.3. STRUCTURE DETERMINATION AND REFINEMENT 
The anomalous difference Patterson map [152] calculated for the SeMet labeled dataset is shown 
in Figure 41. At least, several high intensity peaks could be detected this way coming from cross-vectors 
between different heavy-metal sites. 
 
 
 
 
 
 
 
 
 
 
 
Figure 41: Sections of the anomalous difference Patterson map calculated for the peak data of the SeMet labeled aMBL-2 crystal. 
 
 The phases needed to solve the structure were calculated using the peak dataset from the SeMet 
labeled crystal by SAD. Initial positions for heavy atom sites were calculated with the program SHELX, and 
these positions were the input for the program SHARP. Twenty Se sites (Table 13) were used for phasing 
and an initial map at 3.0 Å was obtained as the final output of the program SHARP. These initial phases 
were extended up to 2.3 Å using the native dataset. 
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Table 13: Final coordinates and occupancies of the Se atoms 
 
(fractional coordinates)  
Se atom x y z Occupancy 
1 -0.0041 1.2641 0.0745 1.2681 
2 -0.0020 1.1110 0.0827 1.1129 
3 -0.0020 1.4074 0.1211 1.4093 
4 -0.0015 1.4759 0.0917 1.4774 
5 -0.0031 1.0084 0.0853 1.0114 
6 0.0003 1.0479 0.0871 1.0476 
7 0.0005 1.2429 0.0759 1.2424 
8 -0.0020 1.2251 0.1159 1.2271 
9 0.0019 0.9507 0.0821 0.9488 
10 -0.0003 1.1225 0.0955 1.1228 
11 0.0041 1.0073 0.0918 1.0032 
12 0.0019 0.8186 0.0827 0.8167 
13 0.0028 0.6666 0.0854 0.6638 
14 0.0010 0.4197 0.0637 0.4187 
15 -0.0007 0.6120 0.1089 0.6126 
16 -0.0035 0.6606 0.1262 0.6641 
17 0.0006 0.3967 0.0891 0.3961 
18 0.0094 0.8201 0.1786 0.8106 
19 0.0064 0.5543 0.1103 0.5479 
20 -0.0011 0.2920 0.0506 0.2931 
 
An initial model of the content of the asymmetric unit was obtained with the program 
AUTOBUILD implemented in the PHENIX suite [121] using the initial phases (in form of Hendrickson-
Lattman coefficients) obtained with the program SHARP.  
The final model was optimized in an iterative process of refinement and manual model building. 
The refinement statistics are shown in Table 14. 
Table 14: Refinement analysis of aMBL-2 
Space group P1 
Resolution (Å) 2.3 
No. reflections 40591 
          Rwork
a
 (Rfree
b
) (%) 28.57 (32.72) 
Number of atoms  
          Protein 6358 
          Water 12 
          Zinc 4 
R.m.s.d.
c
  
          Bond length (Å) 0.009 
          Bond angles (
o
) 1.386 
B factor (Å
2
)  
          Protein (main/side chain) 73.88/73.79 
          Solvent 59.36 
 
6.4. VALIDATION OF THE STRUCTURE 
The final aMBL-2 structure contains four molecules in the asymmetric unit together with 12 water 
molecules and four zinc ions. 
 78 
 
The final model was checked for errors using the MolProbity server [123]. The structure has for 
this resolution acceptable geometry with the fourth molecule (molecule D) in the asymmetric unit highly 
disordered. The electron density is weakest for this molecule as well as for some disordered long loop 
regions (Figure 46). 
 
 
 
Figure 42: Ramachandran plot for each chain (A, B, C and D) of aMBL-2. The structure has for this resolution acceptable geometry. 
Molecule A has 95.9 % of all residues in allowed regions; molecule B has 93.8 %; molecule C has 90 % and molecule D has 90 %.  
 
 
7. Architecture of aMBL-2 
7.1. OVERALL FOLDING 
The monomer of aMBL-2 has an almost globular shape (Figure 43a) with approximate dimensions 
of 55 x 45 x 30 Å. The overall structure exhibits the typical αβ/βα fold for members of the MBL superfamily 
[60, 63] (Figure 43a), with a central core of two facing β-sheets, composed of seven (A1-A7) and six -
strands (B1-B6), respectively, and surrounded by five solvent exposed α-helices (1 (Ala56-Leu62), 2 
(Trp90-Ala93), 3 (Phe199-Tyr203) 4 (Asn207-Arg218) and 5 (Lys236-Glu247)). The first β-sheet, 
labeled as A, is formed by β-strands A1 (from residue Leu11 to Asp13), A2 (His17-Thr23), A3 (Asn34-
Asp40), A4 (Arg43-Ile47), A5 (Leu71-Met75), A6 (Val98-Lys102) and A7 (Leu128-Leu131), while the second, 
labeled as B, includes β-strands B1 (Gln136-Leu140), B2 (Ser143-Pro149), B3 (Phe159-Asp163), B4 (Ile168-
Gly172), B5 (Met224-Pro227) and B6 (Phe233-Gly235). Both β-sheets have mixed parallel (A4, A5, A6 and 
A7; B4 and B5) and antiparallel (A1, A2 and A3; B1, B2, B3 and B6) β-strands.  
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Four of the five α-helices are packed parallel against each other, flanking both faces of the β-
sandwich at the N- (α1-α2) and C-terminal (α4-α5) regions, respectively. A fifth helix, α3, runs parallel to 
the second -sheet and sits close to the floor of the active site, that lies at the interface of the two β-
sheets.  
Both β-sheets are linked on one side by -strands A2 and B5 mainly by hydrogen bond 
interactions, whereas on the other side -strands A6 and B2 are connected by a tight packing of 
hydrophobic residues. Moreover, long connections between adjacent strands of the -sheet as well as 
part of the loop covering the active site are disordered. The main gaps are found between His78 and Ile 84 
(Gap I), that corresponds with a small helix described in other related -lactamases and bringing one of 
the catalytic residues (Asp80). Gap II corresponds to a solvent exposed region also near to the active site 
between residues Leu103 and Ser117, and finally, Gap III is located between residues Val179-Pro185 in a 
region connecting -strand B4 with helix 3. For clarity, the connectivity between these structure 
elements is shown in Figure 43b, where each α-helix and β-strand is numbered sequentially.  
(a)  
 
(b)  
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Figure 43: Structure of aMBL-2. (a) Ribbon diagram of the aMBL-2 monomer. (b) Topological diagram of the structure of aMBL-2. 
Secondary structure elements are labelled according to their position in the primary sequence, also the N and C termini are 
labelled as N and C, respectively. α-helices are shown as cyan and β-strands as pink arrows. GI, GII and GIII represents the 
different gaps in the aMBL-2 model. 
 
7.2. ACTIVE SITE 
The structure of aMBL-2 was obtained from crystallization conditions in the presence of EDTA, 
and we cannot exclude that metal-binding site is partially occupied. The high affinity metal binding site 
(site 1) as defined in other class B -lactamases [63] was His-His-His (His84, His86 and His160 for S. 
maltophilia [153]). 
Based on a superposition of several class B -lactamases, allow the identification of two 
conserved histidines (His78 and His154) near the edge of the β-sandwich in a flexible loop region where 
some of the residues could not be properly traced (Figure 44). The third residue that would bind the metal 
ion is an aspartate (Asp80), a non conserved residue in the canonic metal binding motif (HXDXH/H) that 
could not be traced in the electron density due to the disorder.  
The second low affinity metal binding site (site 2) could not be identified due to the high disorder 
at the region where it should be located. 
 
 
Figure 44: Electron density in the active site of aMBL-2 showing the 2Fo-Fc map (contoured at 1.2σ). Residues are drawn in ball-
and-stick representation with oxygen, nitrogen, and carbon atoms shown in red, blue, and grey, respectively.  
 
 
The superposition of the metallo-β-lactamase L1 from S. maltophilia with the aMBL-2 showed the 
two conserved histidines in a similar localization as in the canonical metal binding motif. The third 
histidine is replaced by an aspartate (Asp80) that could not be seen in the structure (Figure 45). 
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Figure 45: Superposition of the high affinity zinc binding site of L1 from S. Maltophilia (blue) and aMBL-2 (grey). Residues are 
drawn in ball-and-stick mode. 
 
7.3. QUATERNARY STRUCTURE 
The asymmetric unit of AMBL-2 has four molecules showing an oligomerisation state that could 
be associated to a dimer of dimers (Figure 46). 
  
 
 
 
 
 
 
 
Figure 46: Quaternary structure of aMBL-2. Chain A, light 
blue; chain B, dark blue; chain C, red; chain D, pink. 
 
 
The most striking interactions involve C-terminal residues of the two monomers of the dimer 
forming an extended U-shaped structure mutually stabilized by both electrostatic and hydrophobic 
contributions.  
 The dimerization area is formed by residues coming from the extended C-terminal arm 
of one monomer (Asp254, Met256, Glu258) with residues from the helix α4 of the second subunit (Lys208- 
Asn215), establishing predominantly hydrophobic interactions (Figure 47). At the end of the C-terminal 
region, there is a helix3-10 that also takes part of this main dimerization interface by connecting Ser262 
and Gln259 with Arg134 from the second chain. 
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Figure 47: Zoom of the dimerization area between chains A (dark blue) and B (light blue). For clarity, only residues from chain A 
are labelled, but same residues participating in the interaction from chain B are also represented. 
 
 
 
8. Functional assays 
8.1. MICROBIOLOGICAL ASSAYS 
Antibiotic degradation assays were carried out using E.coli DH5 by an adaptation of the Masuda 
method. As can be seen in Figure 48, E. coli cells were able to grow in the presence of OXA, a known class 
D -lactamase [129], as well as aMBL-2 with no significant differences in the inhibition halo around the 
antibiotic disk.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 48: Antibiotic degradation assays by an adaptation of the Masuda method. 
Disks containing: OXA (45µg), (+) control (enzyme with well-known β-lactamase 
activity), BSA (45µg), (-) control (enzyme without β-lactamase activity) and aMBL-2 
(45 µg) were placed around an ampicillin disk (AM10,10µg). Tests were performed 
with Mueller-Hinton agar and inoculums of 5 x10
5
 E. coli DH5α cells/ml. 
 
The susceptibility patterns of AMBL-2 are listed in Table 15. The aMBL-2 enzyme showed a low 
hydrolytic activity against most of β-lactams tested by E-tests, in comparison with others reported MBLs. 
The lowest concentration of the antibiotic that completely inhibited growth (recorded as the MIC) was 
only one or two dilutions higher relative to the control (empty pETRA vector).  
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*P, penicillin; AM, ampicillin; PIP, piperacillin; CF, cephalothin; FOX, cefoxitin; CXM, cefuroxime CAZ, ceftazidime; CTX, 
cefotaxime; FEP, cefepime; IMP, imipenem; MER, meropenem; AZM, aztreonam. 
+ Isolated colonies growth within the zone of inhibition around the strip in E-test assays. 
° Growth among next dilutions in broth microdilution method. Cut-off is dubious. 
 
 
8.2. ENZYMATIC ACTIVITY 
The kinetic parameters of aMBL-2 toward nitrocefin and selected antibiotics were investigated 
(Table 16). 
aMBL-2 exhibits relatively low affinity constants (Km) values, similar to other class B -lactamases 
[References], indicating a high affinity of aMBL-2, particularly to carbapenems but with a significantly 
reduced catalytic efficiency (Kcat/Km). 
 
 
Table 16: Kinetic parameters of aMBL-2 against some β-lactams  
β-Lactam    Km (µM)   
Nitrocefin  68.31 ± 15.7  
 kcat (s
-1
) Km (µM)  kcat /Km (mM
-1
 s
-1
) 
Ampicillin 0.2284 ± 0.011 108.3 ± 6.0 2.109 
Piperacillin 0.2839 ± 0.007 236.1 ± 28.7 12.025 
Cefalotin 0.0325 ± 0.0013 229.55 ± 29.78 0.1416 
Cefuroxime ND 4208.90 ± 260.36  ND 
Imipenem 6.28 E-09  ± 0.32  13.01  ± 0.304 5.827 E-07 
Meropenem ND 1.121 ± 0.104 ND 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 15: MICs of A. baumannii strains with cloned genes used in this work 
Strain   Construction 
MIC (µg/ml)
* 
 
P AM PIP CF FOX CXM CAZ CTX FEP IMP MER AZM 
A.baylyi pETRA  16 4 32 32 32 8 8 4 2 0.06 0.12 16 
 pETRA + N14 16 8 32/256
+°
 32 64 16 8 8 4
+
 0.25
+
 0.12 32 
A.baumannii  
ATCC 17978 
pETRA  32 32 64 256 128 256 16 32 4 0.25 0.25 32 
  pETRA + N14 32 64 128 512 256 256 16 32/256
°
 16 0.25 0.25 64 
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IV. DISCUSSION 
The MBL superfamily constitutes a large and diverse group of proteins involved in a variety of 
biological functions. Their ubiquitous distribution over the three biological domains suggests their 
functional importance and the ancient origin of the family. Members of the MBL superfamily are 
characterized by a similar αββα sandwich fold with a conserved HXHXD/H motif in the active site 
coordinating one or two metal ions (preferentially zinc). This core domain represents the minimal 
structure needed for a functional protein. Besides this domain, members of this family present additional 
domains. These additional domains define the specificity of these members [37, 154].  
From the genome of Acinetobacter baumannii AYE, the genes ABAYE3862 and ABAYE0164 were 
selected that encodes for two proteins belonging to the MBL superfamily. These two proteins were 
selected due to their singular metal-binding motif that differs from the canonical sequence [Reference].  
These two genes, ABAYE3862 and ABAYE0164, were cloned from genomic DNA and their 
respective encoded proteins, aMBL-1 and aMBL-2, were biophysically and biochemically characterized as 
well as their 3D structure determined by X-ray crystallography. 
 
CHAPTER 1:                                                                                                  aMBL-1 
 
The aMBL-1 amino acid sequence has a 99 % identity with a protein encoded by the A1S_2957 
gene in A. baumannii ATCC 17978, which was identified by Hood et al as belonging to a global regulatory 
system that may contribute to the antibiotic resistance in this organism [8]. A subsequent screening with 
PCR confirmed the presence of the aMBL-1 gene in a large collection of pathogen strains isolated from 
different clinical sources, as well as in the non-pathogenic Acinetobacter ADP1 strains. 
 
1. Overall fold 
aMBL-1 has been crystallized in two different crystal forms, monoclinic and orthorhombic. 
Monoclinic crystals were obtained at pH 6.7 with crystallization conditions from a commercial kit and the 
orthorhombic crystal form with an optimized solution at pH 7.5. The structure was solved by MAD using 
an orthorhombic SeMet labeled crystal and refined against a high-resolution native data set at 1.9 Å 
resolution. Also, the structure was solved at 1.7 Å resolution in the monoclinic crystal lattice by molecular 
replacement using the orthorhombic aMBL-1 structure as search model. 
Its structure exhibits a globular overall shape with the typical β-sandwich fold of the MBL 
superfamily that consists of two facing β-sheets composed of parallel and antiparallel β-strands, 
surrounded by seven solvent exposed α-helices (Figure 23, Results Chapter 1). An interesting feature of 
this structure is the presence of a longer C-terminal region built by two extra additional α-helices out of 
the MBL fold. These two helices close over a hydrophobic pocket where a ligand interpreted as benzoate 
that could be assigned as a putative substrate binding site. 
  
2. Putative active site 
Unlike most members of the MBL superfamily, aMBL-1 presented an unusual sequence motif 
made up by residues Tyr-X-Asp-X-Asp/His in the putative active center, where no metal atom was found. 
The electron density found at the putative active site could be interpreted as a water molecule. Some 
other reported members of this superfamily also differ from the canonical HXHXD/H motif. It is the case of 
the class B β-lactamases CphA (PDB 3iof) the most similar structure to aMBL-1, which is also showing an 
unusual coordination of the catalytically essential zinc ion (Figure 49).  
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The metal binding site of YcbL (PDB 2xf4), a member of the glyoxalase type II (GLX2) family, is also 
separate from the canonical sequence motif. The presence of a metal in YcbL is located at the active site 
being responsible for the catalytic activity of this protein [155].  
Only two residues of the putative metal binding motif from aMBL-1 are conserved when 
compared two these two proteins described above. These are the His222 and Asp90. The other two 
residues that in CphA and YcbL are able to bind to metal ions, are not present in aMBL-1. They are 
substituted by Tyr91 and Ile181, two hydrophobic residues that would not coordinate any metal ion. 
These might explain the fact that no metal atoms have been identified at the putative active site, together 
with the lack of enzymatic activity for the assays performed in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 49: Structural alignment and superposition of the active site residues in the metal binding site. aMBL-1 (green), CphA (PDB 
ID 3iof; cyan) and YcbL (PDB ID 2xf4; cyan). Zinc ions are shown as grey spheres. 
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3. Putative binding site 
Every structure of members of the MBL superfamily shows the substrate binding site located at 
the external edge of the β-sandwich, in an open cleft at the interface containing one or two metal ions 
coordinated through residues from the conserved motif HXHXD/H (Figures 5, 7, 8 and 9, Introduction) 
[61]. 
The electron density located close to the putative metal binding motif interpreted as a molecule 
of benzoate could represent the natural substrate-binding site of aMBL-1. The structure of one member of 
the MBL superfamily, PqsE, also contained a molecule interpreted as benzoate as a copurified ligand 
bound tightly to the iron atoms of the active site of this protein [36]. The possible role of this molecule is 
not supported by any experimental results, but they postulate a possible implication in the regulatory 
function of PqsE through a chorismate-derived molecule. 
The binding mode of the benzoate molecule in aMBL-1 is different from that of PsqE. This might 
be due to the lack of metals, or it might represent the real binding mode of the possible substrate of 
aMBL-1 (Figure 27, Results Chapter 1). 
Another common feature of these two proteins is the presence of tunnels that reach the active 
site (Figure 50). Yu et al. [36] postulated that the natural substrate of PqsE could be an elongated 
molecule due to the presence of these tunnels. In the case of aMBL-1 there is a continuous tunnel that 
crosses over the putative active site. The benzoate molecule is located in the middle of this tunnel, as in 
the case of PqsE, indicating also the possibility of an elongated substrate also for aMBL-1. These 
similarities together with the periplasmic location of the protein raises the possibility that it might acts as 
a sensor/regulator binding some molecule that might act as a signal for the bacterium not having any 
hydrolytic activity but acting as a transporter of the extracellular signal. 
 
 
Figure 50: Tunnels at the putative binding site of aMBL-1. (a) Transparent surface representation of the aMBL-1 structure, with 
two tunnels shown as blue mesh. (b) Representation in sticks of the main residues from the hydrophobic pocket. The benzoate 
molecule is represented in ball-and-stick mode. 
 
The structure of aMBL-1 might represent the closed form of the protein. The two C-terminal extra 
helices close over the entrance of the active site and the Trp, present at the penultimate position of the 
sequence, establish a bond with benzoate maintaining this close conformation. 
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4. Comparison with other members of the MBL superfamily / 
Classification 
A search for similar structures deposited in the PDB data bank through DALI [156] showed, as 
expected, that aMBL-1 is similar to members of the MBL superfamily. The best hits are summarized in 
Table 17. Among those structures there are members of the class B β-lactamases, glyoxalase II family, an 
alkylsulfatase, a flavoprotein (rubredoxin) and two quinolone signal response protein (PqsE and ST1585). 
 
 
 
 
 
 
 
 
 
 
 
 
The most similar structures, according to DALI, are members of the class B metallo--lactamases 
followed by other proteins that show unknown or different enzymatic activities. Despite this similarity, 
aMBL-1 presents shorter -sheets compared to the metallo--lactamases, composed by five strands in the 
former while in the latter group they are composed, usually, by seven strands (Figure 49a). 
The structural alignment of aMBL-1 with YcbL (Glioxalase type II) is shown in Figure 49c. The most 
significant differences are the connectivity of helix 3 with the N-terminal -sheet, and the C-terminal 
helices. In this last case it can be observed that the YcbL presents two smaller helices that do not cover 
completely the C-terminal -sheet whereas, in aMBL-1 there are four helices covering this sheet and also 
closing over the entrance of the putative active site. 
The two helices of the C-terminal region of aMBL-1 is a feature not only present in this protein. It 
can be observed in, at least, two other members of the MBL superfamily, PsqE (the quinolone signal 
response protein from Pseudomonas aeruginosa, involved in a quorum sensing pathway) [36] and ST1585 
from Sulfolobus tokadaii [157] that is present also in many other Archaea. In these two cases this feature 
is represented by two and one helices, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 17: Best matches for AMBL-1 according to Dali 
Name PDB ID Z score rmsd Description 
Cph-A 3iof 21.1 2.7 MBL Subclass B2 
SFH-1 3sd9 20.5 2.7 MBL Subclass B2 
SPM-1 2fhx 19.1 2.6 MBL Subclass B1 
BcII 1bmc 19.0 2.3 MBL Subclass B1 
PqsE 2q0i 18.6 3.4 Quinolone signal response protein 
NDM-1 3s0z 18.2 2.4 MBL Subclass B1 
YcbL 2xf4 17.9 2.7 Glioxalase Type II 
ST1585 3adr 17.6 3.3 Quinolone signal response protein 
SDSA1 2cg2 15.8 3.3 Alkylsulfatase 
ROO 1e5d 15.3 3.5 Rubredoxin: Oxygen oxidoreductase 
 89 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 51: Structural alignment of aMBL-1 (blue, 
P21, and green, P212121), PsqE (red), and ST1585 
(yellow). The MBL domain is represented in grey 
and only the extra C-terminal helices are colored. 
 
 
 
In these three protein types the C-terminal helices are located at the entrance of the active site. 
They do not show a similar orientation among these proteins, as can be seen in Figure 51, PsqE has two 
helices and ST1585 presents only one. The fact that in every case only one type of structure, the putative 
closed form, hampers the possible interpretation of the role of this C-terminal feature. 
PqsE and ST1585 are placed into group 0 of the MBL superfamily, without any assigned function. 
The fact that aMBL-1 also presents the C-terminal feature and no known function has been assigned, yet, 
to this protein prompted us to, tentatively, classify the protein into the group 0 of the MBL superfamily. 
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CHAPTER 2:                                                                                                  aMBL-2 
The protein aMBL-2 showed some antibiotic degradation capability and also is most similar in 
overall fold and metal binding site motif to the metallo--lactamases. This data allow its classification as 
part of the class B subfamily of this type of enzymes. 
 
1. Overall fold 
The structure of aMBL-2 shows the typical metallo-β-lactamase αβ/βα sandwich fold. The two 
central facing β-sheets are composed by seven (A1-A7) and six strands (B1-B6), flanked by solvent exposed 
α-helices, two on each side (α1-α2 and α4-α5) packed in a parallel fashion. A fifth helix, α3, lies at the 
interface of the two β-sheets close to the catalytic site. The most characteristic difference with the well 
conserved topology of the metallo--lactamases is the presence of a C-terminal extension that embraces a 
second monomer forming a dimer that has been characterized by analytical gel filtration and analytical 
ultracentrifugation (see Results). 
Most of the members of the class B metallo--lactamases are present as monomers in solution. 
Only β-lactamase L1 from Stenotrophonomas maltophilia showed a higher order of oligomerization, a 
tetramer in solution [153]. aMBL-2 has been found to be a dimer in solution, and the crystal structure 
shows an association that represents a dimer of dimers (Figure 46, Results).  
The dimer arrangement of aMBL-2 has an U-shape that leaves the two active sites at the sides of 
the bottom of this U and separated by 17 Å (Figure 52A). This represents a new arrangement for this type 
of proteins and might influence the substrate selection. L1 from S. maltophilia shows a different mode of 
oligomerization showing a dimer of dimers where every monomer interacts with the other three members 
of the tetramer (Figure 52B).  In L1 all the active sites are not related with each other pointing towards the 
external solvent region arranged in the four vertices of the square that define the tetramer. Also, this U-
shape of the dimer might allow for opening-closing movements upon substrate binding, modifying the 
binding site in the process. 
 
Figure 52: Ribbon representation of the quaternary structure of (A) aMBL-2 with residues at the putative active site represented in 
ball-and-sticks mode and (B) L1 with the zinc ions represented as grey spheres. 
 
The crystal structure of aMBL-2 shows regions of the protein not well defined. One of these 
regions comprises one complete monomer of the four present in the asymmetric unit. Besides this fact, 
the regions with higher disorder might be related to the dimer organization. The arms of the U-shape that 
are composed by one  side of the MBL fold are less defined, and this might support the opening-closing 
movements that might take place during catalysis. 
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Figure 53: Structural alignment of the monomers 
of aMBL-2 (blue) and L1 (green). 
 
The protein aMBL-2 showed a tendency to form tetramers with a dependency to the 
concentration, as seen by analytical ultracentrifugation. These data might explain the presence of a four 
monomers in the asymmetric unit arranged as a dimer of dimers. This oligomerization state (tetramer) 
might not be present in vivo due the high concentrations needed for its formation in vitro. Most likely the 
oligomerization state in vivo and the active form of the enzyme would be the dimer. 
 
2. Putative active site 
The residues involved in the binding of the first metal ion with high affinity of the metallo--
lactamases is well conserved among the class B subfamily of these antibiotic degrading enzymes forming 
the so called canonical binding site (HXHXD/H). An inspection of the alignment of the possible residues 
from aMBL-2 that might constitute this site (H78-X-D80-X-D82/H154) showed the conservation of three of 
them with one substitution, HD80 (Figure 54). The presence of this Asp in place of the canonical His 
should not hamper the binding of a catalytic metal at its binding site. The fact that no metal ion has been 
observed in the crystal structure might be a consequence of the presence of high concentration of the 
EDTA chelating agent in the crystallization condition, which might also explain the high degree of disorder 
observed at the metal binding site. 
 
Figure 54: Sequence alignment of class B β-lactamase enzymes. SPM-1 from P.aeruginosa (2FHX), CphA from Aeromonas 
hydrophila (3IOF), BcII from Bacillus cereus (1BMC), NDM-1 from Klebsiella pneumoniae (3S0Z), L1 from S. maltophilia (2FM6) and 
aMBL-2 from A. baumannii. The yellow squares highlight the main residues from the metal ion binding site. 
 
Enzymatic assays carried out with aMBL-2 showed its capability, although limited, to degrade -
lactam antibiotics. No high activity has been detected with this protein against the antibiotic tested. This 
might be due to the fact that we have not been able to find the appropriate substrate. In any case this 
measured activity indicates the presence of metal ions necessary for this type of enzymes to carry out its 
catalytic activity. 
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CHAPTER 3:                                                                          COMPARISON: aMBL-1 & aMBL-2 
The two proteins of this study were selected using sequence information that allowed their 
classification as members of the MBL superfamily. Also, the differences in the canonical metal binding 
motif raised the curiosity of our laboratory. Due to the relation of these proteins a comparison of both 
structures will be presented. 
 
1. Overall fold 
A superposition of the structure of the monomers of aMBL-1 and aMBL-2 is presented in Figure 
55. A general view shows that both proteins share the MBL fold typical of the superfamily. A closer look 
begins to highlight the differences. 
The main differences that can be observed in the overall fold of these two proteins can be 
summarized as follows: 
aMBL-1 
The presence of an extra helix, 3, located sequentially between both sheets that forms like a 
floor for the active site, and the two extra helices located at the C-terminal closing over the putative active 
site. 
aMBL-2 
This protein presents two more strands in the sheet closer to the N-terminal, and a C-terminal 
extension that protrudes out of the core of the protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 55: Structural 
alignment of the 
monomers of aMBL-1 
(yellow) and aMBL-2 
(blue). 
 
 
2. Dimerization 
Curiously both proteins aggregate forming dimers. A comparison of both types of dimers shows 
that very different regions of the protein are involved in each case. In the case of aMBL-1 the dimer 
interface is made up by the first two N-terminal helices that place the monomers in a back-to-back fashion 
with the active sites far from each other. In the case of aMBL-2 the dimer interface is made up by the C-
terminal extension that embraces the neighboring monomer and leaves both active sites close to each 
other inside the U-shape of the final dimer. 
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3. Active site 
The residues in the putative active sites of both proteins differ greatly. While aMBL-2 resembles 
the canonical metal binding motif of the metallo--lactamases, and most likely will bind a catalytic metal; 
aMBL-1 does not conserve most of the residues of this motif. Also, no metal could be defined in its 
structure indicating a different role in vivo, not depending on any catalytic to carry out its function, and 
serving as a transporter of some kind of signal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 94 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSIONES 
 95 
 
CONCLUSIONES 
 Hemos resuelto las estructuras tridimensionales de las proteínas aMBL-1 y aMBL-2 por cristalografía 
de rayos-X utilizando fases experimentales con cristales derivatizados con seleno-metionina. Ambas 
estructuras exhiben el típico plegamiento metallo-beta-lactamasa, que consiste en dos grupos 
centrales de láminas-beta flanqueados a ambos lados por hélices alfa expuestas al solvente.  
 
 aMBL-1 presenta un dominio adicional formado por dos hélices alfa en la región C-terminal que 
cierran un bolsillo hidrofóbico dónde se localiza el sitio activo putativo.  
 
 La comparación de la secuencia primaria de aMBL-1 con otros miembros de la superfamilia de las 
metallo-beta-lactamasas, nos indica la presencia de un motivo Tyr-X-Asp-X-Asp/His, diferente del 
motivo canónico de unión a metal descrito para esta familia. No se ha podido identificar ningún ión 
metálico en esta región, esencial para la catálisis de un gran número de reacciones dónde 
intervienen miembros de esta superfamilia.  
 
 Se identificó una molécula de benzoato en la intersección de dos túneles que recorren la proteína 
hasta alcanzar el sitio putativo de unión a substratos. La identificación de moléculas análogas se ha 
descrito para PqsE.  
 
  aMBL-1 comparte diversas similitudes estructurales con otras proteínas ya identificadas en la 
superfamilia de MBL’s y que definen un nuevo grupo con función aún desconocida  (grupo 0). 
Aunque no se ha determinado ninguna función específica para este grupo de proteínas, la 
localización periplasmática sugiere un posible papel como sensor/regulador mediante la unión a 
moléculas que pueden actuar cómo señales para la bacteria.  
 
 aMBL-2 exhibe el plegamiento característico de las -lactamasas de clase B, encontrándose en ella 
los elementos estructurales conservados en la superfamilia de las metalo-beta-lactamasas: un núcleo 
central formado por dos láminas beta, de siete y cinco hebras, respectivamente, y flanqueadas por 
ambos lados por hélices alfa. 
 
  aMBL-2 presenta una alta afinidad por ampicillina, piperacillina y especialmente por 
carbapenémicos, aunque su capacidad de hidrólisis es baja. Esto podría ser debido al hecho de que 
aún no hemos sido capaces de encontrar el sustrato apropiado. En cualquier caso, la actividad -
lactamasa indica la presencia de iones metálicos necesarios para llevar a cabo la actividad catalítica. 
 
 aMBL-2 se encuentra integrado en el genoma de varias especies del género Acinetobacter, pudiendo 
ser un reservorio para nuevos mecanismos de resistencia, debidos a la contínua evolución provocada 
por la presión antibiótica. 
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